H:#ffiHffi*? · Morr.rsu: flpeAnoxeHuflTa Ha BoI,I.IKTI KnacupaHr.I yqacrHr,rur4 orroBap{T Ha Mr.rrrrlMaJrHI,ITe aAMI{HucrparuIBHv\ Srznanconra u rexHl,Iqecr[ Lr3r,rcKBaHr.I.fl 3a

$Page 1: H:#ffiHffi*? · Morr.rsu: flpeAnoxeHuflTa Ha BoI,I.IKTI KnacupaHr.I yqacrHr,rur4 orroBap{T Ha Mr.rrrrlMaJrHI,ITe aAMI{HucrparuIBHv\ Srznanconra u rexHl,Iqecr[ Lr3r,rcKBaHr.I.fl 3a$
MEAA,,CBerH flonrerrefirtaoH" - llaoeAytr" EOOA4AM finoBgu?,6yn, "Huxona BanqapoB" Ne ?

www"mbaf2pv.com; e-mait [email protected]

Ynpa1umen meA.: 032/ 603 981; men,/gar<c: 032/ 603 926;603 970

PEIIIEHI4E le?Xl.

rp. Il.rronArrBr 18.02.2019 r.

Ha ourosauue qr. 108, an. 2 or 3OII, perreHr.re }lb 2641 or 06.12.2018 r. na yrpaBr,rren, HaMBAJI,,Cn, flaHrerefiuoH * flnonArs" EOOA 3a orKpr.rBaHe Ha rpoqelypa ro 3OII -,,ny6luunocbcre3aHl{e" c upeAMet: ,r.[ocraBxa Ha JreKapcrBeur.r trpo4yKTrr rro cMr,rcbJra na 3arcona raJrercapcrBeHlrre npoAyKTrr B xyMaunara MeAr.rqrrHa 3a rryxArrre Ha MEAJI ,rCn.[anrerefiMoH" - Il.rronAnr" EOO,(", orKpura c perreHr4e ]\b 2641 or 06.12.2018 r. saynpaBlarenfi Ha MEAJI ,,CB. flaHrereftuon Ilron4un" EOOA, o6snreHrero 3a Kof,roo6qecrnena nopbtlKa e BrI{caHo n Perucrrpa ua o6qecrBeurrre ropbqKr.r uol J',lb 01020-2018-0004, pr cneA Karo ce 3aro3Hix c flpororon N 1 or I 1.01 .2019 r., flpororon J\b 2 or 24.01.2019 r.u flporoxor l',lb 3 or 29.01.2019 r. ua KoMr.rcrrrra, H€BHaqeHa c Mo, 3aroBe.u Ns 57 or I I .01.2019 r.u npr.rKnroqura pa6ora sa 15.02.2019 r.

I. OBflBflBAM KJIACIIPAHETO

Ha yqacrHllullte n ny6ru.IqHo cbcre3aHr4e rro orAenHr4 r4 caMocroflTeJrHlr HoMeHKnarypHr4eAunprr\u B HI{3xoArIII pea rlo Kplrrepvfl, ,,:oair-larEcr<a {eua" - crrracHo npuJtnrceruue Jlb 1,Hepa3AenHa qacT oT HacToflrrloTo peureHr,re.

Morr.rsu: flpeAnoxeHuflTa Ha BoI,I.IKTI KnacupaHr.I yqacrHr,rur4 orroBap{T Ha Mr.rrrrlMaJrHI,ITe

aAMI{HucrparuIBHv\ Srznanconra u rexHl,Iqecr[ Lr3r,rcKBaHr.I.fl 3a Aorrycrr{Mocr, 3aKperreHh B

o6ssreHuero 3a o6qectseHa Eopbqra u AoKyMeuTarllrrra 3a yqacrr.re. Yuacruzqure B

lpolleAypara ca rrpeAcraBvrltv B rIbJIeH o6eu u Aocrarbtrnr,r r.r3r{cKyeMr.r AoKyMeHTr.r.Brg ocrosa Ha roper.r3noxeHoro

II. oTIpEAEJIf M 3A II3IIbJIHI,ITEJI

Ha o6Iuecreeuara rroptqKa rlo oTAeJIHI,I v caMocroflTeJIHLI HoMeHKJrarypHLI eAr,rHrrrl]rKnac[paHlIre Ha nbpBo M.f,cro - cbrJracHo npunmrceHue JW 1, nepa-:4eJrHa rracr or HacroflrrloroperrreHr{e.

Peureurero roAnexu na o6xareaue r 10-AueBeH cpoK or yBeAoMrBaHero npe4 Kouucufl,3a3arrlr{Ta Ha KoHKypeHrlr.rf,Ta - rp. Co(prz4 6ytt.,,Br,rroma" }lb 18.

Opran, rcofiro orrosapq ga upoqetrypure no o6xaflnaHe:OQuqua;rno Har{MerroBaHrre: KoMEcI,rs 3a 3arrIHTa Ha KoHKypeHrlurraAgpec: Co(prax 1000, 6yn. ,,Br.rrorrra" Ne 18

E.ner<rp ouHa rro Iq a : {[email protected] gLlnrepner aqpec: www.cpc.bg

EBPONETCK}IcLK)3Eaponeicxr Sou4 saperhoHafiHo pa3Brlrrie

.-,",.;::=;"#fr

ISO 9001:200& rSertltled lntqroeO SWerf, /H:#ffiHffi*?

npxnoxeHtre Nq 1 KrM PeueHre N9 379 or 18.02.2019 r.

ACARBOSE

1 Ttproacf,a rrra

2

2

2

XA'MEHOBAH'E

Aroba tabletl00mgx30r,]ot{o6Afi TAE/I. looMr X 30

509

60 0,2317

LOOO A

1000 0,1235

a1,104

2 (DboHrxc

ACENOCOUMAROL

I CooapMa TpeiAxHrAA

2 OboHHkc

ACETHYILCYSTEINE

L OboHxxc OapMa EOOA

ACETYLCISTEIN

L CooapMa TpeiAxHr AA

2 OboHrxc

ACETYLSALICYLIC ACID

7 OboHuxcoopudEOO,4

2 Tbpz@cxo tuzo

ACETYLSALICYLIC ACID

1 rDboHxxc OapMa EOOA

ACICLOVIR

ADEMETIONINE

1 OboHrxc OapMa EOOA

CI,IHTPOM 16, 4Mrx 20

CI.IHTPOM TAEN.4MT X 20

10omo tobl.

100m8 tabl.tabl.

4mo tobl.

4mg tabl,

tabl.

600ma pulv,

500m9 pulv.

pulv

600mo Powd.

600m9 Powd.

110,4 SANDOZ

Hermes

PIIZER H.C.P

5,38 CORPOR

Pfizer

Men Pharma

GmbH & C

"qaixa+apMa13,902 Brco[oxa 100

Novartis Pharma

123,5 GmbH 100

MERUS LABS

Arlq Eo.TAEr, 500Mr x 10

caue 500Mrx 10

Aqq-AqETUnqhCTEhH ANYT npax

600Mr x 10

100

100

100

40

40

40

200

200

200

100

100

100

800

800

800

150

150

150

80

80

120

120

I

1,099

a

7t5,2

7.752

5,8

I

2,$8

100

96,69

115,2 Arzneimittel

Salutas Pharma

43,96 GmbH

SANDOZ

771 AKTABI,IC-OTC 100

"qoilxoQopMs385,55 BucoKoKo tu,34

Salutas Pharma

ADEMETIONINE

1 OboHtrxc OapMa EOOA

TPAHCMETHT AMN, 5OOMT X

slxwuf,lTPAHCMEThI $r. 500Mr + pa3rB

sMrx5

AKTH.fllt3E Or. 50Mf X1 lKyInAlAKThTM3E cyxa aMn. SOMr+ pa3rB. x

1

AMBROXOL VP, Sytup, 15 mq/s ml-720 ml, ., Pqck: 7

TPAHCMETll'I TA5'I. 5OOMT X 10

TPAHCMEt h.0 fi. 500Mr x 10

116

4soo a

4500 0,038

4500 00857

a

o,0672

0,0695

350

30

o,0432

a

0,0528

100 I

100 0,0638

13,'t4 ADIPHARM l-TD

13,9 CodapMa M

Pharmaceutical

PFIZER H.C.P.

7,92 CORPOR

Pfizer

222 MYTAN

226 Abbvie S.r.l.,Avara

TEVA

PHARMACEUTICAI.

s

TEVA

PHARMACEUTICAL

4,32 S

TEVA

TOnnA HAnhTXA 600Mr X 10

AUE|USAn XAPAUO TA6n, ilNMr X30

Aphl gostr@reslstont toblet, 700m9 x30AUU- AtIETl,1nqhCTEt'lH npax 100Mr x

ACnETAKC T46,l. 500Mr X 20

AAXOAPM

AUETrlrlhH 16. 500Mr x 20

Powd.

100mo tobl.

l^Omg tobt.

700m9 tobl.

tabl.

500m0 tobl.

500m8 tabl,

400no tobl.

sq:Omo tobl,

500m9 tabl.

tabl

s1oma fl.

500m9 fl.

ft.

20% 100m1 fl.

20% 100m1 fl.

50mo powd,inf,

50mg powd.inf.

100 na tobl.

100 mP tabl.

30mq tobl.

30mg tabl,

15mq/5ml-1O0ml sir

15mg/5ml-100m1 sh

L2,22

100 I

100 108

I

6,1776 4942,08 MYTAN

FAMAR L'

EyI EHO-Hq3n5

100

99

ALBUMIN IHUMAN)

ALENDRONIC ACID

1 OboHr(cALLOPURINOL

1 oboHxKc rDapMa EOOA

ALPRAZOLAM

1 OboHx(c OapMa EOOA

ALPRAZOLAM


ALTEPLASE

I OboHxxc OapMa EOOA

MEYMUH Or. 20% x 100Mr -

70ma tobl.

AM'OTEPOH TABN. lOMT X 30

700mo tobl.

MOAATPA TA5L 100Mr X 50 100m9 tabl.

ra61 100Mr x tabl,

XCAHAKC TAE'I. O,sMT X lOO

KCAHAKC 16.0.5Mr x 100

0,5mq tobl,

0,5m9 tabl.

tabl.

KCAHAKC TA5n, 0,25Mr X 100

XCAHAKC 16. 0.25Mr x 100

0,25md tobl,

0,25m9 tabl.

tabl.

100

100

100

BOEHRINGER

57216 INGELHEIM

Delpharm Reims;

57344 BoehAMANTADINE

AMBROXOL

1 CooapMaTpelAxHrAA COTIBOTIAH 16. 30Mr x 202 (DboHilxr CO,flBO,TIAH

AMBROXOL

1 AuqcoH

180

50000

5000050000

Lo,t4t 7050 KRXA d.d.

7

Eemnpw A&340,56 ivzopuf,

100

2 MedeKcOOA

3 CoOapMa TpeiAxHr AA

Ambrex, Syrup, 75 mg/s ml-iln mL -

, Pqck: 7

COnBOTIAH ctrp. 15Mr/sM, 100M,

AMSPEKC CllPOn AETCKh

15mE/5nl-700m1 sit

15mg,/5ml-1OOml sir

Ho6ea QopMq

U6,8 EOOP" Eb

453,6 KRKA d.d.

518,4 NOBEL PHARMA

355,32 Medochemie

3il CoOapMa M

384 MEDOCHEMIE Ltd.

B.BRAUN

9840 MEISUNGEN lOO

AMIKACIN

I OboHxxc

AMIKACIN

1 MeAooapMa EOOA

2 CoOapMa TpeiArHr AA

3 OboHrxc

AMIKACIN

1 MeAoOapMa EOOA

2 co+apMa TpeiArHr M

3 OboHxxc

AMINO

AC I D+ 42%G LU CO SE+ SO Y-B E A N

OI L REFI N E D+ MEDIU M.CHAI N

TRIGLICERIDES+OLIVE OIL

REFINED+FI5H OIL,RICH IN

OMEGA 3 ACIDS,ELECTROLYTE

FREE,1970ML

AMINOPHYLLINE

AMIODARONE

1 OboHxxc OapMa EOOA

AMIODARONE

I rDboxxxc OapMa EOOA

10 mo/ml 100 ml

2.5 mo/ml 100 ml

Smo/ml looml ecoflok

AMXKAT{HH 6 SPAyX sMr/Mn

CereMrqrxaMr.l2S*rlwzlMt ffi

AMhXAI-lhH aMn. 125Md M^ 2Mt x LO 125m9/ml 2ml amp.

AMn. 250Mr 2Mn X 10

250mo/ml 2ml omp,

CereMrqrHaMn.2sOMtlM2Mt 250mg/ml2mlamp.

AMl/lKALlhH aMn. 250Mt/Mt 2M^ x L0 250m9/ml 2mI amp.

AMn. 500Mr 2M,rt x 10

cMoot{a6l,t8EH

24mo/ml 10ml omp.

COOAOITI,tH aMn. 240Mr/10Mr x

s0

KOPAAPOH TA5'. 2OOMT X 30

20oma tobl.

200m8 tabl.

tabl

150ma 3ml omp.

150m8 3ml amp.

aMf,.150Mr/3M, x 6

4

2

3

2000

2000

200

200

200

200

at,7766

7,82

I

0,0176

o0226

100

97,52

700

77,88

100

96,68

96,02

2000

2000

2000

2000

6000

5000

1s00 a

1s00 0,58

1500 0,6961

2000

2000

20u)

2000

9.

3,366

?4

6732 Medochemle 100

6800 CoOapMa M 99

7224 MEDOCHEMTE Ltd, 93,19

FRESENIUS

jo00 a3000 0,r5r5

xoPAAPOH AMn.150Mr3MI X

6lKWnf,l 1O2O SANOFI AVENTIS

SANOFI.AVENTIS

AMLODIPINE

7 ObuuxcoopMoEOOA2 MedoQopMoEOOA

smq tobl,

smg tobl,smg tobl.

tabl.

lOO0mq film.tqbl.

1000ms lilm.tabl,film.tabl.

1OO0ma/20Oma x5 fl.

1000m8/200m9 x5 fl.

875mo/125ma

film.tqbl.

875m9/125m9film,tabl.875m&/125m8

film.tabl.

87smgl725mEfilm.tebl.

875m9,/125mg

film:tabl.

TEVA

PHARMACEUTIUL

35,2 5AM'OTEPOH TAEN. sMT X JO

Axcen m6. sMz

AMTIOBACR 16. sMr x 30

45,2 Medochemie

Actavis h.f.,

SarKa

949,92 Sandoz GmbH 100

AMOXICILLIN

I CooapMa TpeiAxHr AA OCnAMOkC 16. 1000Mr r 12

2 O6oHrRc ocnAMoKC TA6I. 1000Mr X 12

2400 A2400 0,39s8

AMOXICILLINE CLAVUUNIC35 ACID

1 CooapMa TpeiArHr AA

AMOXICILLINE CUVULANIC

A M OX I CI LLI N E CLAVU LAN I C

i7 ACID

I M€AoOapMa EOOA

2 CoOapMa Tpe;AxHr M

3 OboHxKc OapMa EOOrq

AMOKCHK,IAB 0r, 1,2rp x 5

AMOKSIKLAV, Powder for solution forinjection,1000 mg/200 mt, mB, Pack:

MeAoxraB 16. 875Mr/125Mr

AMOKChrAPA 16. 875Mt/725Mt x !4AMOKCT4MAB TA6/r. 875Mr/125Mrx20Climox film?coated tablet 875

Lek

11350 Pharmaceuticals

Lek


4000 a

4000 2,84

200

200

2100 a

2100 7,0745

2100 7,]1174

2100 !,779

2256,45 Medochemie

RANBAXY

2333,94 LABORATORIES

2349,9 SANDOZ

"9airagapma3000,06 BhcoKoKa

38 )Npe6ud AMPICILLIN

25mcx70 Powd. lnf.

Tarchomin

AMWRIPTILLINE

I OboHr(c

ANTI-D /RH /

AQUA AD INIECTABILIA

I OboHf,xc itapMa EOOA

AMPICILLIN SULBACTAM

I CooapMa TpciAxHrAA


YHA3l.lH 0r. 1,5rp x t

YHA3AH On. 7,sfP X 7/RYtt/|P,/

Unasyn, Powder for solution for5 s, -. Pack; 1

AMHTPTNTTNUH TA6N.

AI{BA PEAECT],I,|ATA ERAUN AMN.fiMnx203641227CTEPhrl143tlPAHA BOAA aMn. 10Ma x

50

Vitamin C VP, Solution for iniection,100 m&/ml - sml, m& Pack: 10

Vitamin C VP, Solution for injection,

100 mg/ml - 5ml, mg, Pack: 1

BhTAMhH C aMn. 500Mr/5M, x 10-

3

2

2

1000/5o0na fl.

1000/500m9 fl.

1000/500mg fl.

25na tqbl.

5251u/nl l125mco/nl) -

TOml dmp.

10ml amp,

2000 g

2000 3,61

2000 3,624

Haupt Pharma

7220 Latina

PFIZER H.C,P,

7248 CORPOR

7280 Pfizer, hratue50

100

99,51

100

97,53

96,96

MEDA

PHARMACEUTICAI,

200

200

200

I

0,23t 100

7a

ASCORBIC ACID

1 AxacoH

2 MeAexc OOA

Tpeia!HrASCORBIC ACID

ATRACURIUM

1 Cooapma TpeiArEr AA

SOOma sml amp, 8OO

500m9 sml amp. 800

500m9 5ml amp.

BernpoM AA,

675,2 6\ rcprl

BernpoM A,q,

688 EbnraprF

704

800 0,86

800 0,885ml

201ma/2ml omp. 100BI,ITAM}IH C aMn. 200mr/2ma x 10

ATRACURIUM

I CooapMa TpeiAxHr AA

TPAXP}IYM aMn, 50mr/5ma x 5Tracrium, Solution for injection, 10

ml - 5 ml. -. Pack:

TPAI(PUYM aMn. 25Mr/2,5Mr x 5Tracrium, Solution for injection, 10

GlaxoSmithKline

291,2 Man

GlaxoSmithKline

298 Manuml -

50ma 5ml omp.

50mg 5ml amp,

25mo 2,5m1 omp.

25mB 2,5m1 amp.

lmo/ml 7ml omp.

50no tobl.

50mg tabl.

50mg tabl.

s00 g

500 2,924

500 2,94

a

1,456

GlaxoSmithKline

1462 Man

GlaxoSmithKline

1470 Manu

200

200

200

200

200

200

80

80

200

200

ATROPIN SULPHATE

AZATIOPRIN

I CoOapMa TpeiArHr AA

2 MeAexc OOA

3 O6oHrRc

AZITHROMYCIN


ATPOnhH CYTIOYPhK aMn. 1Mr/1Mr1500

ls00

1200

12001200

2000

2000

2000

15000

15000

}IMYPAH1650Mrxl00IMURAN, Film coated tablet,50 mg, -,

Pack:100

100 a

100 0,3316

100 0,34

H€umann PCS

33,16 GmbH

Heumann PCS

34 GmbH, Ge

ASPEN EUROPE

180 KRKA

SarxaH0apMa -34 Pa3rDa

185,6 KRKA

PLIVA HRVATSKA D.

1250 0.

OapMa{eailrHf,

SarxaHoapMa -114 AynHf,q

115,2 AKTABI4C

50MT X 100

A31.t5UOT TA5r. 2s0Mr X 5

A3ATPl4-n kanc. 250Mr x

A31.t51,tOT TA6L500Mr X 3

6n. 500Mr x 5

tabl.

250mo film.tobl.

250m9 film.tabl.

5o0mq fl.

500mg fl,

AZITHROMYCIN

I Oboxx(c OapMa EOOA

BARIUM SULFATE WITHOUT

SUSPENDING A6ENTS

BBROMAZEPAM

1 CooapMaTpelArHrAA2 <Dsoruxc

BEMIPARIN SODIUM

I CooapMa TpeiAxxr AJq

2 OboHlKc

BENTOTHIAMINE

/PYRIDOXINE/

CYANOCOBALAMIN/

L rDboHxxc OapMa EOOA

BETAHISTINE

DIHYDROCHLORIDE

1 CooapMaTpeiArHrAA

I0,9

1667

100

77,t4100

100a

1,855

12,5ft

,IEXCOTAH 16. 3Mr x 30

NEKCOTAH TAE,N. 3MT X 30

3f EOP aMtr.3,500 lU10.2M^x2

TOO1 ondK.

odax.

3mo tobl,

3mg tabl,

35OOlU O.2ml sol.ini.

35001U 0.2m1 sol.ini,

3500tu

40mo/90mo/25Omca

9S2t40mg/90m8/250mcg

caps.

40mg/90m9,/25Omcg

16ma tobl.

16mg tabl.

Laboratorios

8600 Farmace

BERLIN CHEMIE

a

0,09s

a

4,3

9.

0,08

MENARI

a

0,3351

0,3498

WOERWAG

67,22 PHARMA

C.P,M.Contract96 Pharm

Catalent Germany1200 SchBECTISO 16. l6mrx 60

2 MeAoOapMa EOOA

BETAHISTINE

DIHYDROCHLORIDE

I Medo$opMo EOOA

2 OboHuKcOopMoEOOA

BeprxMeA16. 16Mr 16mg tabl.

Bepmuqei m6. 24m

TEBAEEXUOTA6N. 24MT X 60

SETACEPK 16. 24Mr x 20 tabl.

s@p

OTIOCTEPOH AMn./2Mr+5Mr/1Mfl (5mB+2mgl /ml -1ml

x'lli.wual amp(5ms+zmB) /ml -1ml

OnOCTEPOH aMn.1Mr x 5

70ma suDp,

Sr|ON6HC E6r LoMr x 30

6h3OnPO,nOn AKOPA TA6n. loMr X

30

10ma film.tqbl.

10mg film,tabl,

film.tabl

6rlOK5l.lC E6r sMr x 30

5h3OnPO.nO,fl AKOPA TAEn. sMr X

30

5mq tobl.

5mg tabl,

tabl.

2mo/ml 2ml omp.

SPOMXEKCl1H aMn. 2ml

15000 0,0834

15000 0.1052

BETAMETHAZONE

COMBINATION

1 OboHr(c OapMa EOOA

3

3

2

24mq tobl.

24mq tobl,

24mg tobl,

2,5ma tobl.

2,5mg tabl.

2,5mg tabl.

iooo300o

3Un

3000

1200

1200

7200

I

0,0593

2

a0,7642

o2102

60 2,2584

50 2,26

50

492,6 Medochemle 70O

ACTAVIS DIVESTED

630,6 PRO 78,72

Mylan Laboratories1590 S

100

35,58 Niche Generics Ltd. 100

36.72 ACCORD 96.9

SarxaHoapMa -2100 AynHxq2150 AXTABt4C

i030

60

61

BISACODYL

BISOPROLOL


2 OboHhxc

BISOPROLOL FUMARATE


OboHrxc

BROMHEXIN

BROMOCRIPTINE


2 Co$apua Tpei4rxr A.[

500

500

600

3mo tobl.

Smq/ml 4ml omp.

Smo/ml 4ml omp,

smt/ml 4ml amp.

5mg/ml 4ml amp.

20mo/ml lml omp.

2omg/ml 1ml amp,

20mg/ml 1ml amp.

1ml

10ma tobl.

tabl.

50Oml sol.inf.

500m! sol,inf.

500m1 sol.inf-

L

o,o32

304

30 0,2108

30 0,2747

30 0,2153

200

I

3,7144

3,78

200

5,324 MEDOCHEMTE t-td.

6,441 CooapMa AA

Medochemie

Dr Falk Pharma

AstraZeneca AB,

186,72 ASTM ZENECA

189 Cenexi

AstraZeneca AB,

189,5 Swed

1200

1200

20ooo a

20000 0,10s

BROMHEXIN gmq tobl,

1 CooapMa TpeiAx8r Arq SPOMXEXCtlH 16, 8Mr x 20 - A(E8rc 8mg tabl,

2 OboHtrKC Al( 8mq tabl.

BROMHEXINE 4mq/5ml-125m1 sh

EPOMxEKChH crp. 4Mr/5M, x40

SPOMOKPTnTTH TAE t.2,5Mr X 30

SPOMOKPhnThH 16. 2.5Mr x 30 -

CodapMa

100

98,18

BUDESONIDE

BUPIVACAINE SPINAL

1 OboflxEc OapMa EOOA

2 co6apMa TpeiAtrHr A.q

BUTYLSCOPOLAMINE

I MeAooapMa EOOA

2 OboHxKc OapMa EOOA

MeaoKeMh 16.2,5Mr

xanc. 3Mr x 100

Marcaine Spinal Heavy, Solution forinlectlon, 5 m&/ml - 4 ml, -, Pack: I

MAPRATH CnilHM OL5Mr/MI4MtXSlRWUf,lMAPKAhH SPINAL aMn.5 nr/na 4un5

Marcaine Spinal, Solution forinjection,5 mg/ml - 4 ml, -, Pack: 1

SycxonaMoH aMfl , 2omr/MrSvcKonAMrlH AMn. 20MT/MI 1M/l

50

50

50

50

100

98,79

20oo a2000 1,134

2000 1,7424

2268 Medochemie 100

2284,8 MEDOCHEMTE Ltd. 99,26

B.BRAUN

13,8 MELSUNGEN

rDapMax -

4950 Ebrrapxr OO

x10

6YCKO,nh3fiH aMn.

BUTYLSCOPOLAMINE

CALCIUM CHLORIDE

D I HY D RAT E O. 276/5 O D I U MLACTATE 3,12G/SOOIUM

CHLORIDE 5G/POTASSIUM

CHLORIOE O.4G B 1L 6AHKA


SYCKOrllt3}lH Ap. loMr x 20 -

XAPTMAH 11HO. P-P sOOM.|I BRAUN

3641230

Ringer Lactate Baxter, Solution for

10

10

10

I

1,38

CALCIUM GLUCONATE

1 MeAexc OOA

Calclum gluconate Farmak, Solutlonfor injectlon,95.5 mg/ml-10 ml(exaraareHreH aa 89 Calclum), -,

Pack: 1

8.94mo/ml 70ml omp.

8,94m&/ml 10ml amp.

2500

r,98

CANDESARTAN

CARBAMAZEPINE

I CooapMa TpelAxHr AA

CARBAMAZEPINE

I OboH{xc OapMa EOOA

CARVEDILOL

1 MeAooapMa EOOA

2 (DboHrkc

CARVEDILOL

1 OhoH{*a

CEFAZOLINE

1 MeAeKc OOA

2 OboBtrKc

CEFEPIME

1 MeAooapMa EOOA

2 TbproBcxa rxQ

3 MeAeKc OOA


CE F O P E RASO N E 5U LBACTA MI MeAooapMa EOOA


xMu. rnloKoH14KyM

KAHAECAPTAI{ AXTAB}lC n6a 16mr

OHH,lEnCTH 16. 200Mr x 50

TAEn. 200Mr X 50

HEYPOTON PET. TA5,I. 3OOMT X 50

76 ma tobl.

16 ms tabl,20oma tobl.

200mg tabl,

tabl.

30Omd tobl.pr

300m9 tabl.pr

700

700

600

600

500

600

600

500

200

200

200

150

150

150

150

300

300

300

a

o,o754

I

0,t234

568

L0,0296

AWD.Pharma

45,24 GmbH & Co

G.L.PHARMA GMBH

Malta Ltd

G.L.Pharma GmbH

8,288 Medochemie

17.584 ARTAB'lC

G.t.PHARMA

74,04 GMBH

HEYPOTOn PETAPA 16. 300Mr x 50

ABepHor 16. 5,25MrHAPBh-IIEKC TA5,[I 6.25MT X 30

KAPBl,I,,IEKC TAE,l 12.5MT X 30

CEFAZOLIN PANPHARMA2 G,

Powder for solution for ini€dlon,2000, mt, Pack: 1

.Mhn or.2rP, x 10

Aroaqeo 0r. 1r

Bacteripime powder for solution forinjection/infusion 1 gx 1

Bacteripime, Powder for solution for

injection/lnfusion,1, g, Packr 1

Cyrqeo 0r. 1000/1000Mr

cvnqEo on. lrPllrP x 1

CY-nqEO 1rp/1rp npax :a rxx p-p $rx25

qEOOnEPA3OH AEP 2rp rp. 3a xHHp-p $a x5

Me,aoueo Or.2r

nPOOl,lKC trpax cycn.250Mr/5Mr

100Mr

cvcn.250MT/5MI 60M-n

nPooxKc TA6n, s00Mr x 10

rlEoTA3r,rAhM-MXn Or, 1r X 10(EFADIM, Powder for solution forinjection, 1000, m& Pack: 1

Kefadim powder for solution for1cx1

MeAaxcoH 0r. 1r

CEFTRID(ONE.TCHAIKAPHARMA,

Powder for solution for injection, 1, g,

Pack:1

Ceftriaxon - Tchaikapharma powder

for solution for injection 1g x 10

MEAAKCOH O.n. 1rP X 100

5,25ma tabl.

6,25m9 tabl.

tabl.

12,5nq tdbl,

tabl.20 ini.

2g ini.

280

280280

80 280

a3,9348

3,94

3,98

1000 I1000 71,s26

1000 11,88

1000 12

PANPHARMA

254 Laboratori2,54

100

100

100

70 fl.

ls fl'

19 fl.

lg

SarxaH0apMa -

1448 Pa3rpa lOO

1453,2 Medochemie 99,64

1724,4 MEDOCHEMTE Ltd. 83,97

MIP Pharma GmbH

786,96 Medochemie

"tlaixa+apMa788 Bxcoxoxa

9aixaQapua796 Bhcokoxaq

FRESENIUS KABI

629,1 Medochemie

645,3 MEDOCHEMIE Ltd,

667,5 Medochemie Ltd.

343,5 Ho6er OapMa OOA

VALEANI/PHARMA424.8 SWTSS

500,4 NOBE! PHARMA

501 Ho6er

836,4 MIP Pharma GmbHqaiKaOapMa

838 Bxcoxoxac

"laixagapua

2559,6 Medochemle

qaixaOapMa

2580 BHcoxoxac

"9aixa{apma2600 BtrcoKoxa

2552 MEDOCHEMIE Ltd.

6arxaHOapMa -

100

99,87

98,86ft.

ft.

1oo0/1000na fl.

1000/r000mg fl.

1000/1000m9 fl.

20 fl.

2ell.2sfl.

11525 Medochemie 100

11880 MEDOCHEMTE Ltd. 97,02

12000 Medochemie Ltd. 96,053

3

CEFOPERAZONE

1 CooapMa TpelAx8r AA2 l'/erodapMa EOOA

3 OboHxxc

CEFOPERAZONE

I M€AooapMa EOOA

2 OboHrxc OapMa EOO.q

200

200

200

200

a

7,24

7,266

o/t.2rP. x 10

MeAoqeo Or. 1r

MEAOUEO O/1, 1rP. X 10

125mo/sml -60m1 susp

nPOOl,lKC npax cycn.125Mr/5Mr

ft

1o fl.

1g fl.

1s fl.

Lill.

I4,194

4,302

2

a1,668

7

100

97,49

CEFPROZIL

CEFPROZIL

I CooapMa TpefiArHr AA

2 OboHhkc

CEFPROZIL


CEFTMIDIME

1 OboHxrc OapMa EOOA

2 MeAeKc OOA

CEFTRIAXONE

1 MeAooapMa EOOA

2 MeAeKc OOA

3 TbproBcKa rrra

4 OboHuxc OapMa EOOA

30

250md/5ml-60m1 susp

250mg/5ml-60m1 susp

50ona film tobl500m9 film tabl

7o fl.

ls fl'

1g fl.

10 fl.

1s fl.

1s fl.

200 a

200 4,t82

200 4,r9

304

30 11,45

fl.

ft.

fl.

ft.

1g

1g

2000 a2000 1,2798

2000

2000

2000

!,29

1,3

L,326

1,48

100

99,81

99,57

100

99,27

98,45

96,52

5

CEFTRIAXONE 20 x 10fl fl.2960 Pa

1 MeAeRc OOA

2 CodapMa TpeiAxHr AA

3 OhoHr(c

CEFUROXIME

1 CooapMa TpeiAf,Hr AA

2 TbprcBcxa rtrra

3 OboHhKC

CEFUROXIME

1 Tiproa€(a rxra2 MeAooapMa EOOA

Ceft rlaxone Panpharma, Solutlon foriniectlon, 2, 8, Pack; l0L-IEOTPhAXCOH 0n. 2rp 50Mn,x 10 -

Mhn

o.n. 2rP x 50

qEOYPOKCXM AEP 1,5rp nPAX 3A

rHx. p-p x5

Lifurox powder for solution forinjection/infusion 1. 5g x 10

AXCETT,IH On. 1,5r X 1

Lifurox powder for solution foriniectlon/lnfuslon ,., 5g x 10

AxceuH 0r.1500MrAKCEThH dr. 1.5rD x 100

OYPOqEO16 500Mrx 14

AXCEO TAE/I. 500Mr X 20

AKSEF 500, Film?coated tablet, 500,

mg, Pack: 20

Lifurox film?coated tablet 500 mg x

10

AKcerrH T6. 500Mr

29 x 10fl fl.

29 x 10fl fl.

x 10fl fl.150ono x 70 fl.

1500m8 x 10 f,.

1500m9 x 10 fl.

/ 100m1 sol. lnf.

fllm.tabl.

500m0 4ml dmp.

500m9 4ml amp.

4ml

7000ma 4ml omp,

1000m9 4ml amp.

4ml

500mo film.tobl.

s(nmg fllm.tobl.500m9 film.tabl.

500m9 film.tabl.

150mo/ml - Aml omp.

150m9/ml - 4ml amp,

25000

25000

2,08

2,r

PANPHARMA

52000 Laboratori 100

chephasaar chem.-

52500 pha 99,05

57OOO MEDOCHEMIE Ltd.

1000

1000

1000

1000

I

t,54

7,62

t,824

I

1,62

1,559

a

0,99

0,996

100

95,06

EarxaH0apMa -

1540 Pa3rpa

',r.tafixaOapMa

1520 BxcoKoKa

CEFUROXIME

1 CooapMa TpeiArHr AA2 OboH{Hc OapMa EOOA

3 MeAeKc OOA

4 Tbproscxa rxra

3

5

2

2

2

1500na x loo fl.

1500m9 x 100 fl,1500mg x 100 fl.

x 100 fl.

500ma filn.tobl.500m8lilm.tabl.500mg film.tabl.

500mg film.tabl.

500m9 film.tabl.

10mo/ml-2mlomp,

2ml

25ma/ml-2ml omp, 80

0.5mo/ml-70m1 orol

700ma 70ml amp. 300

100m8 10ml amp.

100m9 10ml amp.

10ml

4o0ma / looml sol, lnf.

7824

"qaixa0apMa486 Brcoxoxa 100


540 Medochemie Ltd. 90

170,58 KRKA d.d.

184,8 NOBEL PHARMA

Ho6e, OapMa

192 EOOA, sb. "ttaiKaoapMa

202,4 B\coRoRa

203,78 Medochemie

13,32 AKTABT4CAA r006arxaH+apMa -

300

300

300

300

200

200

200

200

200

200

100

r00

100

I0,8529

0,924

0,95

7,O72

a

0,1332

I1,36

100

92,31

88,84

84,28

83,71

CHLORAMPHENICOL

I OboHf,(c OapMa EOOA

film.tabl.

250mo cops,

x,loPHXTPOMI,tqXH KAnC. 250MrX 20 250m9 caps.

x,lOPHhTPOMhLlhH xanc. 250Mr x

zo

CIPROFLOXACIN

1 MeAexc OOA


3 Co6aoMa TDeiatrHr AJI

CIPROFLOXACIN

CIPROFLOXACIN

CIPROFLOXACIN


CHLOROPYRAMINE

MEPrO3AH aMn.

x.nOPnPOMA3HH aMa. 25Mt I ilt2M, x l0

Ciprofl av, Concentrate for solution

for lnfusion, 10 mt/ml -10 ml, mg,

Pack:1

uhnPhHon AMn. 1o0Mf 10M,r xslKYrne/

q}lnPHHO,l xHoy3. p-p 400mr x

2OOM^

qHnP}{HOrl xHoy3, p-p 200Mr x

qhnPooIoKcAtll.tH TAE,. 500MrXlOAK

16.500Mrx 10

coMA3l,rHA AMn.500Mr/4MI X

slKvruEl

COMA3hHA aMn

coMA3l,rHA AMn.1000Mr/4Mn X

slxvfuBl

COMA3I.lHA aMn. 1000Mr/4Mr x 5

KAnnoH TAdn. 250Mr X UXreprMeA 16. 500MrOPOMh.rlhrq 16. 500Mr x 14

Klacar llm?coated tablet

l{,r.rHAAMXqr,rH KA6X

AMn.ls0Mr/Mr 4M, X 1

KrhHAAM14LlhH aMn.150Mr/Mr 4M,x5-Mhn

2OOmo / 700m1 sol. lnf. 30000

100m1 sol. lnf.

500mo film.tobl.

500mg film.tabl.

Warsaw Pharmace

297 utic

298,8 KRKA

354 KRKA d.d.

5016 UNIPHARMA

5080 Ferrer lnternational

33s00 KR(A d.d.

99900 KRXAd.d. 100

205,2 ARTABT4C AA249,6 KRKA d.d.

100

100

CHLORPROMAZINE

HYDROCHLORIDE

100

99,4

300

300

300

I

6,7

600 I

600 0,342

500 0,416

5000

5000

2999

2000

2000

3000

3000

3000

L

2,s08

I

3,8592

I

1,836

2,52

CITICOLINE

1 OboBf,Kc OapMa EOOA

CITICOLINE

1 OboBrKc OapMa EOOA

CLARITHROMYCIN

7 .,boHutc OopMd EOOA

2 MeAo$apMa EOOA

3 CooapMa TpeiAtrHr M

CLINDAMYCINE


700 04529700 0,5588

700 0,6743

700 0,8857

11577,6 UNTPHARMA

11880 Ferrer lnternatiohal

TEVA

PHARMACEUTICAL

324,03 S

461,16 Medochemie

472,01 KRKAd.d.

"9aixa$apua619,99 BrcoKoKa

700

1N)

70,26

68,6s

1000

1000 1836 FRESENIUS KABI lOO

chephasaar chem.-2

CLINDAMYCINE 3o0mo cdps.

110

111

CLONIDINE

CLONIDINE

CLOPIOOGREL

I CooapMa TpeiAf,rrA,q


COLCHICINE

1 Oboflrxc OapMa EOOA

COMBINATION / B COMPLEX

CYANOCOBALAMIN

CYANOCOBAUMIN

DESLORATADINE

1 CooapMa TpelA{Hr AA2 OboHhxc

DEXAMETHASONE

1 obo8f,x. OapMa EOOA

2 cooapMa TpeiAtrHr M

OIAZEPAM

DICLOFENAC SODIUM

1 AxacoH

2 MeAexc OOA

3 OboHxKc OapMa EOO.A

TpefiarHr

DICLOFENAC SODIUM

I Aracoa

2 MeAooapMa EOOA


x,XHAAMULIHH AEP E xanc 300Mr

0,75ma tobl.XTOOA3OTHH 16. 0.15Mrx 50 0,15mc tabl.

0,lsma/ml 1ml omp.

)(,lOOA3OTHH aMn. 0.lsMr/Mr lMr

2500

2500

Ear(aHOapMa -

459 Actavis Ltd; Ada

x

4O0O L

4000 0,95

}(,On}lAOfPE, 16, 75Mr x 30 -

A(EBrc

AEKCAMETA3OH XRKA AMN.

4Mf I Mn LMA X 2SIOnAROBKA/

AENCAMETA3OH aMn.4ur f ut 7nn x

10-CoOapMa

Dexamethason KRKA, Solution for

fil m

xo,lxrlqxH TAEI, x 25

0,5ma tobl.

0,5m9 tabl,

16.0.5Mrx 25 tabl,

Bl,lTAMhH B 12 aMn. 10O0Mxr/1Mr x

10

soomca 1ml omp.

BHTAM]4H B 12 aMn. 500mxr/1ma x

10 1ml

lomka/ml 15ml drops

EOECTM 5Mr o{rM.16 x l0

5 mo film tobl

5 mg film tablfilm tabl

2ml amp,

looomca 1ml omp.

mo/ml 1ml omp. 12OOO

4mglml lml amp. 12000

4mglml 1ml amp. 12000

75mo film.tobl.

75mg film,tabl.

50md 2ml omp.

50mg 2ml amp.

tabl.

5md tobl,

smg tabl.tabl.

4500

4500

4500

1000

1000

1000

a

0,702

1035

I

0,s38r

2

100

100

100

30

30

50

50

PHARMASELECT

53,8I INTERAN

PHARMA SELECT

54,2 INTERN

Bl.lTAMtlH B KOMnIENC aMn. 2Mr x

10

50

a

0,247.2556

Stada Aunlemittel12,35 A 100

96,64

L

0,3s85

0,36

78 NOBEL PHARMA

4303,2 XRKA

4320 CoOapMa Aa

4320 KRKA. d.d.. Slovenia

SC ROMPHARM

920 COMPANY

"ilaixa0apMa940 Brcokoka

9aixa{apma950 BtrcoxoKa!

997.2 KRKA

BsnpoMAA,184 EtrrapE

KRKA, d.d. Novo185 Mest

222 MEDOCHEMIE Ltd

Salutas Pharma

244 GmbH

BernpoM A&11040 Errrapf,t

11322 Medochemie

13320 MEDOCHEMIE Ltd

Laboratorlos

53 Menarin 100

BERLIN CHEMIE

100

99,61

100

97,87

95,83

100

99,46

82.88

100

97,s|

82,88

DEXKETOPROFEN

I CoQapma Tpeigrxr A,Q

2 TbproBcKa nxra

3 Meaexc OOA

4 OboBxxc

DEXKETOPROFEN

1 CooapMa TpeiAxxr A.q

2 OboHtrxc

DIAZEPAM

1 CooapMa TpeiAx8r AA AtlA3EnAM 16. 10Mr x 20

2 OboHukc OaoMa E TAEn. 10Mf X 20

OIAZEPAM

1 CoOapMa TpelAf,Hr AA AtlA3EnAM 16. 5ilr x 20

AEXCXEIOnPOOEH 50mr/2ma rxx p.

p x5 PoMo

Dexketoprofen-Tchaikapharma

solution for injection 50m9,/2ml x 100 50mg 2ml amp.

Dexketoprof en-Tchai kapharma,

Solution for injection or concentrate

for solution for infusion, 50 mg,/2 ml,

mg, Pack: 1 50mg 2ml amp. 1000

AMn.50Mr

AEKCOOEH 16. 25Mr x 10

25mo film-coot.tobl.

25mg lilm-coat.tabl.

TA6/1. 25Mr X 10

70ma tobl.

10mt tabl.6arxaHOapMa -

103,8 AynHxq105,84 AKTABI4C

SarxaH0apMa -14,8 AytrHf,q 100

L

o,92

I

0,53

0,96

100

100

100

600

600

a

0,173

x

100 I

100 0,148

1000

1000

164

a

0,358

0,3774

0,444

70mq 2ml omp,

aMn. 10Mr/2M, x 10 2ml

25ma/ml 3ml i,m, omp.-

i.m. 500

Dirlof€nac VP, Solution for lnlection, 25mg/ml 3ml l.m. amp..25 m8/ml-3 ml, -, Pack:lo Lm. 500 0,368Naklofen, Solution fo. lnjection, 75 2smg/ml 3ml i,m. amp.-mg/3 ml, mg, Pack:1 i.m. 5OO 0,37MMhPM AMn. 75Mr 3Mn X 5 25mg/ml 3ml i.m. amp.-

/t1VIt491 i.m, 5oo 0,444

aMn,75Mrl3Mr x 5

25mgi/ml 3ml i.m. amp,-i.m.

75ma iml i.v.,i.m omp.-i.v,,i,m i0000

Diclofenac VP, Solution for inrectlon, 75mg 3ml i.v,,i,m amp.-25 mglml-3 ml, -, Pack: 10 l.v,,l.m 3OOO0

75mg 3mli,v.,i.m amp.-ArMxpa, aMn. 75Mr 3M, i.v.,i.m 30OOO

MMhPM AMn. 75Ma 3M,rl X 5 75mg 3ml i.v.,i.m amp.-

IRYIAA/ i.v.,i.m 3oooo

75mg 3ml i.v.,l.m amp.-

s00 I

500 0,0624

604

60 0,14s3

13500 KRKA d.d

Bemnpo$ A,&

73,96 EvzopuE

76 CotbopMoq118.8 SANDOZ

SarxaH0apMa -8,718 Pa3rpa

ARTAB14C

27,795 BEAUFOUR IPSEN

Beaufour lpsen

5375 lndus

DICLOFENAC SODIUM

7 AuocuDlclofenoc VP, Gel, 7% - 50 g, -, Pock:

1

DOPAMIN WZF, Concentrate forsolution for lnfuslon, tO mg/ml - 5

ml, mg, Pa€k: I

AOnAMilH aMn. 4% 5Mr x 10

AOnAMIH AMn,4% 2ooMr/5Mn X

10 POLFA

Doxazosin - Tchaikapharma tablet4mg x 30

TAEn. 4Mf X 30

AOI(CXqXl(,lrlH t(AnC. 100Mr X 6

AR

AOI{CXqXKnr{H rizt

APO CnA3 16. /OMr x 20

HO-U.tnA TAM. 40Mr X 24

Drotaverin Vp, solutlon for lnrection,

20 mg/ml-2m|, -, Pack: 10

Drotaverin VP, Solution for injection,

20 mg,/ml-2m1, -, Pack: 1

HO-unA AMn.40Mr/2M,n X

2slKYftlF/

60o oel.

60q qel.

609 gel

0,25mq x 50 tobl.

0,25m9 x 50 tabl,

x 50 tabl.

0,25mo/ml 2ml amp.

2ml

50ma tobl.

50mg tabl.

3.76a pulv.

3,768 pulv.

3,

9,9ama/99.6ma/5ml

250na/50n1 fl.

fl.

10ma tobl.

tabl.200ma 5ml omp,

200m9 5ml amp.

200m9 5ml amp,

4mq tobl.

4mg tabl.

tabl.

700mo cops.

2omo/ml 5ml omp.

5ml

40ma tdbl.

40mg tabl,

21mo/ml zml qmp.

2omg/ml 2ml amp.

20mg/ml 2ml amp.

20mg/ml 2ml amp.

20

20

2020

100

97,32

I

3,698

3,85.94

2 Cobop6oTpeilduilzAA OEIOPAH ee, 1% 6Up - CoOdpMd

3 OboHrxc fu !o/o501

Dl60xtN

I rDboHxxc OapMa EOOAAr4roHcxH TA5r. 0, 25Mr X 50

RICHTER

AhfOXChH 16. 0.25Mr x 50 -

G.Richter

DIGOXIN

AHfOxCl,lH aMn, 0,25Mt I M^ 2Ma x

10

DIMENHYDRINATE

I CooapMa TpeiAf,Hr AA AUMEHXI,IAPXHAT16. 50Mr x 30

2 OboHxxc

OIOSMECTITE


2

2

500

s00

75

75

75

I0,3706

DIPHENHYDRAMINE

DOBUTAMINE

1 OboHf,x(

DOMPERIDONE

1 OboHxxc

DOPAMINE

1 MeAexc OOA

2 cooapMa TpeiAhHr M

3 O6oHrxc

DOXAZOSINE

1 Ttproacxa rBra2 OboHHKc OapMa

DOXYCYCLIN

DOXYCYCLIN

DROTAVERINE

1 CooapMaTpeiAxHrAA2 OboHxKc

DROTAVERINE

1 A{acoH

2 MeAe(c OOA


ENALAPRIL

7 Co&opMdfpeiduHaM2 hH6Horeg


4 TbproBcRa rurcENALAPRIL

7 Co$opMofpeiduHzM2 OboHuxcoopqoEOOA3 hH6iloreq

30

30

600 7,78

500 r,82

60

60

100 I

100 s,13

MEDOCHEMIE Ltd. lOO

70ma tqbl.

lomgtobl,10mg tabl.

10mg tabl.

21mo tobl.

20mgtobl.20ng tdbl.20mg tabl.

tabl

smo tobl,

5mg tabl.

5mg tabl.

100

97,8

96,32

100

98,82

97,9

100

99,04

100

97,72

69,86

500 I

600 0,2107

600 0,224

600

100 a100 0,1355

100 0,195

5000

0,336

Warsaw

1068 Pharmaceutica

1092 Pharmaceutica

POLPHARMA

"qai(aoapMa126,42 8{coxoxa

135,8 KRKA

Tarchomin

13,55 AA]4OAPM EAA 100

PEHAnPiln m6. 70M2 x 28

Enpril

EHnPh,n TA5,l. 10MT X 60

Enalapril-Tchaikapharma tablet 1.0mg

x30

6000 I

6UN OMs6000 0,0523

6000 0,054

5000 0,055

I

o06860,07020,0982

7297

BernpoM AA2016 Eb tapua

BernpoM

2040 AA,6brraptrs

2059,2 SANOFI AVENTIS

ionxoxSopuo -270 AynHu4

313,8 14H6xorex OOA

324 INBIOTECH

"9aixa$apua390 Bico(o(a

82,i2 Actdvis hl; Adovis4,24 INBIOTECH

777,84 A{'uorex OOp\

"qaiKaOapMaBtrcoKo(a

6aaxaxQapma -55,98 AynHxq56,52 INBIOTECH

6000 0,34

5000 0,3432

18OO L

1800 0,0311

1800 0,0314

PEHAnPnn m6. 20Ma x 28

EHflPUN TAEN, 2OMT X 20

Enpril

1200

UN7200

1200

1200

Enalapril-Tchaikapharma tablet 20mg4

ENALAPRIL

I CooapMa TpelArHr AA2 Obo8hxc OapMa EOO,q

PEHAnPltrl 16. 5Mr x 28

EHnP[/t TA5/1. 5MT X 60

FLUCONAZOLE

1 MeAexcOOA

FERROUS

S U LF ATE /CYAN OCO B ALAM I N /

FERROUS SULPHATE

1 OboHxxc OapMa EOOA oEPOTPMyMET TA5r. X 3016 325Mr x 30

Dlflazon, Solutlon for lnlectlon, 2

m8/ml- 100 ml, m& Pack:1

Arixra, Solutlon for lnlectlon, 2,5

mg/0,5 ml, ., Packr I pre-filled

syringe (glass)

wlth an automatic safety

system

AP|4KCTPA AMn, 2.5Mr 0.5M/l X 10

2

2

3

50mg/1.33mg,/0.70m8

325ma tobl.pt,

325m9 tabl.pr,

zma/ml 101mlfl.

2mglml 100m1 fl,

50ma cdDs,

50mg caps.

700mq cops.

100m9 caps.

0,4ma tobl,

0.4m9 tabl.

1s00 I

1s00 0,10281500

300 g

300 16,22

300 L6,87

I

0,5375

340 A

340 1,3813

340 7,4175

200 a

200 0,0462

TEOFARMA S,R.T. -

154,2 rr

LEO Laboratorles

Lim

315 lnnothera Chlouz

Goedecke GmbH

5ar(aHoapMa -

BernpoM AA,

254,4 Errrapxf,

BernpoM Aa,

256 6brraprn

272

SarKaH0apMa -

I(RXA, d.d. Novo

4866 Mest

SarxaH0apMa -75,25 Pa3rpa

77,49 ARIABI,.C

Earf,ax0apMa -469,642 Pa3rpa

FLUCONAZOLE

1 CooapMa TpeiArHr Alq2 (DboHuKc (DaoMa E

FLUCONAZOLE

I CooapMa Tp€iAxHr AA2 OboHxK(

FOLIC ACID

I CooapMa TpeiArHrAA

FONDAPARINUX SODIUM

1 MeAexc OOA


140

1rrc

140

OYHrOTIOH xanc, 50Mr x 8

ovHroroH RAnc. 50Mr x I

OYHrOIOH (anc. l00Mrx 15

ovHro,]oH KAnc. 100Mr x 15

HEOOOTIXK OO/l XEBA Kl,tCErl.lHA

16, 0.4Mr x 90oo.nilE8a KI4CE_nIHA TAE_n.0.4Mr X

ta bl.

2,5mo O,5ml sol.ini. 50

2,5m9 0,5m| sol.ini.

2,5mg 0,5m1 sol,inj.

50

50

7,72

7,794

7

FOSFOMYCIN

I CoOapMa TpeiArHr AA

2 OboHxKC

FUROSEMIDE

I CoOapMaTp€iA{xrAA

FUROSEMIDE

1 OboHf,(c OapMa EOOA

FUStDIC ACtO

GABAPENTIN

APhKCTPA aMn. 2.5

OOCOOMl,ll.lhH CAUIE 3rp x I30 qron,

3g gran.

20mq 2ml omp.

20mg 2ml amp,

2ml amp.

40mo tobl,

40mg tabl.tabl

70mq/o 5o drops eve

3)0ma coDs,

5ma/nl 1ml omp,

1ml

l1mo/ml 1ml omp,

1ml

0,1% 15o una

80mo 2ml omp,

80mg 2ml amp.

80mg 2ml amp.

2ml

0,3% 5q oint.eve

0,3% 5s olnt

125mI svt.

125m!

3EHThBA

MOHYPM CAI.JJE

104

10 4,92

a0,046

1000 I

1000 2,38

lsoo a1500 2,92

Aspen Notre Dame

356 de 100

ASPEN PHARMA

359,7 TRADING 98,97

Aspen Notre Dame

362 de 98,34

Lablana

49,2 Pharmaceutic

ANGELINI PHARMA

6800 CooapMa A'q 100

ACCORD-

5,52 AKTABhCAA lOO

2 MeAeKc OOA

3 codaDMa T

GENTAMICIN

G E N TAM YCI N + B ETA M EfH ASO

oYPO3EMl,lA aMn, 20Mr/2Mr x 10

ovP03EMhA A(OPA On. loMr/Mn2Mn X 10

OYPAHTPH,I TAEN. 4OMT X 12

16. 40Mr x 20

OYCilTMMhN 10Mr/M, oqHx (anxt

H}lBMIIH aMn, lM, x 10

HhBATI}{H aMtr. l%1M^ x l0

Gentamicin VP, Solution forinlectlon, 40 mg/ ml - 2 ml, -, Pack:

10

Gentamicin VP, Solution for injection,

40 mg,/ ml - 2 ml, mg, Pack: 1

f EHTAM14Ut'lH aMn. SOMt /2M^ x lO -

fEHTAmHUhH BXX{bH yHra, orea0.1%

Bronchoton, Syrup, 4,6 ngl',75

20000 I

20000 0,34

20000 0,3672

lN720

5

5

GAUNTAMINE

HYDROBROMIDE

GALANTAMINE

HYDROBROMIDE

500

800

183 GENTAMICIN

GENTAMICIN

1 Axacof,

5

5

0,318800

800

800

5

5

900

900

0,32 99,38

6LAUClNE+EPHEDRINE

ml 125 s, -. Pack; I

30ma tdbl.

EernpoM AA

GLICLAZIDE

1 CooapMa TpeiAxHr AA

GLIMEPIRIDE

7 Co$opMoTpeilduHzM2 .rboHuKc.Dop0o EOOA

GLIMEPIRIDE

7 Co$op$oTpeiduHzM2 .iboHuxc.,op$o EOOA

HOPMO.qhAE 16. 80Mr x 60

80ma tqbl.

80mg tabl.

2ma tobl.

2mg tobl.

2mq tdbl.

tabl.

1mo tobl.

7mg tobl,lmg tobl,

5%1O0Oml sol.ini.

5%1000ml sol,ini.

5%1000m1 sol

i2,25a pulv. Sprov

32,258 pulv, Spray

300

300 0,0s8

300

609

60 0,0513

60 0,0528

150

1s0 0,029

750 0,0296

150

nt4MEPArl m6. 2Mz x 30NilMEPNI TASN 2MT X JO

3,078 Adsvish,I,,Actovl lU)3,768 AKTABUCM 97,76

,,'.taixa+apMa

6LUCOSE

GLUCOSE

GLUCOSE

1 Oboxf,xc OapMa EOOA

tablet 2mc x

XA,IOnEPXAOI 16. r.sMr x 50 .

G.Richt€r

OXCI,IKOPT aepo3or x 32.25rp

OKChKOPT CNPEIZ 32.25TP

nUMEPA1 m6. l&z x 30

nUMEPA' TAsn LMr X 30

illoxo3A xHo. P-P 10% 500MnBRAUN 3641212

435 Actovls h.f., Adovi+/U AKTABUCM

"9afixadapua9 BHcoxoxa 94

268,8 NOVO NORDISK

269,4 Novo Nordisk a/s

B.BRAUN

768 MEI,SUNGEN lOO

5xo+apM510 HHxeHepxHl

B.BRAUN

660 MEL

Bieffe Medital

14,05 Gedeon Richter Plc.

1 GEDEON RICHTER

100

97,97

tablet 1ms x 30

GLUCAGON

1 OboHxxc OapMa EOOA iloIArEH Xrnox]tT lMr

1ms tabl.

lmo fllmg fl

r/IOKArOH 6r. 1Mr HYPOKIT ft

10% 10ml amp.

frlnRO3A aMtr. 10% 10M, r 50 10% 10ml

40% 10ml omp.10ml

rrpKo3A 75r? x75a x 7 pulv.

759 x I pulv.

r/lloRO3A cauera x 75ro - XxMaxc x110% 500 sol.inf.

10% 500 sol.lnf.

100

78

10

10

10

a26,48

195

196

197

2

2

500

I74 148

200200

500

s00

i030

30

a0,768

15 9,072

23,04 XI.iMARC 100

Tarchomin

24 Pharmaceut 96

SLUCOSE ECOFLAC

GLUCOSE ECOFLAC


GLUCOSE ECOFUC ECOFUC

ilIACfMACOBA EAHKA OT

NONUET4NEH C ILBA

CAMO3ANE9ATBAUU

CTE P hJI H h N O PTA /LD P E /.

GLUCOSE CT.6AHKA

GLYCERIL TRINITRATE

I Obof,rKc

HALOPERIDOL

HALOPERIOOL

1 CooapMaTpefiArHrAA

2 OboHxxc OaDMa EOO.o

HEPARIN SODIUM

1 Oboxxxc OapMa EOOA

2 CoOapMa TpeiAhHr A4

3 Meaexc

HYOROCHLORTHIAZIDE

I CooapMa TpefiAxHrAA

1 CoOapMa TpeiArHrAA

2 OboHhxc

rrloHO3A l,lHOY3. P-P 5% x 500Mr

nr.6aHxa

rnloKo3A hHo. P-P 5% 500MIBRAUN 3641210

500 a

500 7,02

500 7,32

r00

5% 500m1 sol.inf.

GLUCOSE SAXTER 5%, Solution for50 q/l - 500 ml, s. Pack: I 5%

somo 50ml sol.inf.

sma/ml 7ml omp. 300

1ml

1,5mo tobl.

1,5m9 tabl.

250

G.POHI. BOS(AMP

4704 GmbH 100

1000

350

250 0,0562

s0as0 6,072

50 5,08

900

900 0,1125

900 0.1164

15 0,275

303,6 POTPHARMA

304 Pharmaceutica

Ev,l EIO.HU3n5

EarxaHoapMa-

101,25 Aynxx{a

AKTABhC

Tarchomin

4125 Pharmaceut

136,08 POLFA TARCHOMIN

250O0lU sml fl.

XEnAPHH Or, 250001U 5 Mrl.Xlo 250001U 5ml fl.

XEnAPhH Or. 250001U/5ml x106p 250001U 5ml fl.

Heparinum WZF, Solution foi50001U/ml - 5m1, lU, Pack: 1

250mo/5ml omp.

I,IMYHOBEHTH-HHTAXT aMn,

250Mr/5Mr x 10

AEXHAPATXH HEO 16. 25Mr x 20

25ma tobl,

25mg tabl.

HEO TAE,fl, 25MT X 20 tabl

100

99,87

H YD RO CO RTISO N E T O XYTETRA

CYCLINE

HYDROGENIUM

PEROXYDATUM 7OO A700 2,558

30% 1100ml sol.

30% 1000m1 sol- 1797,6 XUMAKC

213

214

HYOROXYETHYLSTARCH

(POLYIO-2-

HYDROXYETHYUSTARCH

TRIHYORATE. SODIUM

CHLORIOE ,POTASSIUM

CHLORIDE, MAGNEZIUM

CHLORIOE HEXAHYDRATE)

1 OboHrxc lDaoMa EOOA BOrvEEH rHO.P-P 6% 500M,lHYDROXYZINE

1 OboHxxc OapMa EOOA ATAPAKC TA6N. 25MT X 25

100

100

2

HYDROXYZINE

IBUPROFEN

ICHTAMOL

IMIPENEM CILASTATIN

PAJTBOPUM,

SbP3OAEilOBAUI

I CooapMa Tp€lAxHr AA


INSULIN HUMAN JO%

DISSOLVEO INSULIN AND 70%

ISOPHANE INSULIN

1 CoOapMa TpeiAr8r AA

IOPAMIDOL

IRON OII) - HYDROXIDE

DEXTRAN COMPLEX

ISOFLURANE

ISOLEUCIN 2.56 /LEUCINE

3.7G/ LYSINE 3.3G

/METHIONINE 2.156/PHENYULANINE 2,55G

/THREONINE 2.2G/

/ARGININE 6G/ HISTIDINE 1.5G

/A].r''NINE 7G/ GLYCINE 5.5G

/PROLINE 5.66/SERINE

3.25G/ltROSlNE

ATAPAKC

16, 25mrx

rOMr/Mr 100Mr

HXTAMOTI yHrB. 10% 15rp - rar€a

lmipenem Cilastatin Panpharma,

Powd€rfor solutlon for infuslon, 500

AffiPAnxA HM PENF, Qa. 3ma x 5 -

xvMv.nhH R AMn. 100tu/Mn 3Mn x5

Humulin R suspension for injection

MXI(CTAPA 30 HM PENF,0r. 3Mr x

5

Humulin M3 suspension for injection

SCANI"UX 370, Solutlon Ior iniedion,370 mc l/ml - 50 ml. ms. Pack: I

COSMOFER, Solutlon forInlectlon/infuslon,50 mg/ml - 2, ml,

Aerrane, lnhalatlon vapour, liquid,Packr 1

4Omq/ml-700m1 susp.

70a uno,

50ono/500mo fl. 1000

6% 500m1 sol.inf.

6% 500m1 sol,int.

25mq x 25 film.tobl.

25mg x 25 film.tabl,

2soo I

2500 0,1099

2500 0,1108

UNION CHIMIqUE

274,75 BELGE

FRESENIUS KABI

6arxaH0apMa -

rMEH-OAPMA

25mo x 50 tobl.

1,5mo tobl,pr,

1,5mt tabl.pr.

PANPHARMA

18480 Laboratorl

60

il

5

5000

5000

300

300

300

a

0,058

INDAPAMIDE

I CooapMa TpeiAxHr AA HHAInAM SR 16 1.5m8 x 30

2 OboH[xc sR TA6_n.1.5Mr X 30 AK 1

6arxaH0apMa -17,4 AynHr{

17,64 AKTABI4C AA

1444 Novo Nordlsk a/s 100

ELI LIILI & ELANCO

7446,12 G 99,81

Nederland 94,01

222,72NovoNordiska/s 100

Nederland

Sanoahemia

Pharmacosmos

100u1/ml3nl fl.

roouuml 3ml fl.

100u1/ml 3ml fl.

lolul/nl 3nl fl.

100UUml 3ml fl.

370molml 50mlfl.

50 mo/ml - 2 ml omp,

100n1 fl.

100m| fl.

200 a

200 7,22

200 1,2336

309

30 7,424

236

2

2

2

3

ISOSORBIDE DINITRATE

1 CooapMaTpeiAxHrAA

2 OboHxKc

ISOSORBIDE DINITRATE

I CoOapMa TpeiArH. AA2 OboHrxc OaDMa EOOI

ISOSORBIOE DINITRATE

I CooapMa TpeiArHr AA2 OboHxKc

ITRACONASOLLE

1 Oborrxc OapMa EOOA

IVABRAOINE

7 CoOopMoTpeilduqzM2 Vt{6uoreq3 (bhoHrxc OaoMa E

JOD-BENZIN

KETAMINE


LYSINE 6,6G /METHPNINE

4.3G /PHENYLALANINE 5.1A/THREONINE 4,4G

/TRYPTOPHAN 2G/ VALINE

5.2G /ARGININE 12G

ISOSORBIOE OINITRATE

I rDboHxxc OapMa EOOA x3oKET CnPEF 15Mn 300 AO31,l

ly'3OKET aepo3o, x 15Mr

UNION CHIMIqUE

250,8 BELGE TOO

AESICA

1.25mo/dos15ml iOOd

tplgv1,25m8ldoslsml 300d

spray

1,25mg,/dos15ml 3OOd

5ma tobl.

5mg tabl.

tabl

10mo tobl.

10mg tabl,tabl

20mq tobl,ptolona

20mg tabl,prolongtabl

700 mq cdps.

100 mg caps.

100

7.5mo film.tobl.

7,5m9 film.tsbl.7,5m9 film.tabl.

7.5mc film.tabl.

600a sol,

sol.

50Oma/10m1 omp.

500m9/10m| amp,

200mq tobl.prolonq

200m9 tabl,prolong

70qmo powdet ond

solvent fot sol.for ini.

700m9 powder ond

solvent fu sol.fot inj.

700m9 powder ond

solvent lq sol.fot inj.

100mg powder and

solvent for sol.for inj,

100mg powder and

201ml svr

200m1 syr

200m1 svr

X3OAllHHT PETAPAT6. 20Mr x 30

146I. 20Mr X 30 AK

I3OKET16. sMrx 60

il3oKEr TAE/|, sMr X 60

HTPAXOHA3O'I OYHTH3O'I

xAnc.l00Mr x 15

tIHEBUKA 7.sMr OrnM T6 x 60

Corledin

KOP,NEHTOP TA6'I. 7,5MT X 56

AESICA

30,21 Pharmaceutica 100

UNION CHIMIQUE

30.6 BELGE 98,73

SarxaH0apMa-

4,644 Ayf,Hxqa 100

EarxaH0apMa -9,276 Aynrrq

VALEANT/PHARMA

55,44 SW|SS

MEDICO UNO(F

gmxoH$opMo -725 AynHurl

202,888 Genepharm S.A.

353,975

XhMAKC

799,2 GEDEON RTCHTER 100

Bemflpw Arq,

800,7 Evzopun 100

Lek

U5 Phomoceutlcols 9457

1458,8 SANOFI AVENT|S 54,47

1485 Sanofi-Aventis S.P.A

69,12 MIP Pharma GmbH 100

Chephasaar chem.-

qaixa0apMa

420 Bxcoxoxac

478.8 NOBEL PHARMA

Ho6ea

204

20 12,54

20 L2,58

I

0,1007

0,102

a

0,0387

300

300

300

120

720

120

t20120

560

550560

560

100

100

100

ITTPAKOHA3O,II OYH Tl43O/l xanc

100Mr x I

604

60 0,924

60 0,9387

I

0,2250,3623

0,632r

a

o,0773o,o7a4

a7,992

8

9.

6,9r2

7

100

62,r

1515

KETOPROFEN

1 CooapMa TpeiArHr AA2 OboHrRc OapMa

KETOPROFEN

I Auocu

2 MedexcOOA


LACTULOSE


co,l. 600r x

xA,flrnco,l oI.500Mr 10wt/t.x 5

KMilnCO.n aMn.50Mr/1Mr x 10M, x

5

KETOPROFEN VP 50 mg/ml solution

fu lnjedion,Pock: 70

XErONAL Solutlon for lnjectlon, 700

mq/2 ml, mq, Pock: 7

nPooEHhA on. 100Mr t.v. x 50

IAKryrO3A,Mhn ChPOn 200M,l/lAl(rynO3A-Mhn cxp. 65r/100Mr x

i6a36 0,4954

450 a

1,778

1,88

3,264

450

10

10

10

LAEVODOPA/EENZERAZID

LAEVOOOPABENZERAZIO

UEVODOPABENZERAZID

l-r''NSOPRASOLE

I MeAexc OOA2 OboHrxc OapMa EOOA

LAVA N D U LAE AETH E R O LEU M

LanzAcld, 6astro reslstant capsule,hard, 30, mg, Pack:30

,tAHCOnPOn XAnC 30Mr X 28

,flAHCOnPOn 30 xanc. 30Mr x 28

3omo cdps.

30mg caps.

30mg caps,

1400

t4001400

1400

a

0,3

0,342100

87,72

87,59

1 OboHx(c150oma cops. 270

MONTAVIT

LERCANIDIPINE

HYDROCHLORIDE

1 CooapMa Tp€iAxHr AA2 OboHrxc

LEVOCETIRIZINE

LEVOFLOXACIN

I CooapMaTpelAxHrAA

2 OboHrHc OapMa EOOA

LEVOFLOXACIN

nonhETunEHoB on.

1 MeAexc OOA

2 OboHhxc OapMa EOOA

L EVO F LOXACI N CTbKN E H ON,

1 MeAexc OOA

LIDOCAINE

I OboExxc OapMa EOOA

2 Merexc OOA

3 TlproBcHa rrra

70ma film tobl.

10mgfilm tabl.film tabl.

500mq film.tqbl.

500mt tilm,tabl,

500m9 film.tabl.

300

300

L

0,o773

0,

L

1,0057

7,0629

a

5,62

5,784

a

0,8615

0,91

0,92

a

1,806

1,83

7,44

L

2,544

2,58

a

0,258

100

98,5

100

94,62

,lEEOOnOKCAql.lH Karc, 500Mr x 7 -

Teaa

/IEBOOnOKCAUT4H TEBA

TAE,n.500Mr X 7

23,19 Actavls Ltd, : Actav

Pharmach€mie

@3,42 S,V,,rACTAVIS DIVESTED

637,74 PRO

"9aixa$apma

Flexid, Solution for lnfusion, 5 mg/ml- 100 ml, -, Packr InEBOOnOKCAUhH KASh O/1.

sMr/MI looMn

film.tabl.

5ma/ml 100n1 sol.inf.

smg/ml l00mlsol,lnf.

5mg/ml 100mlsol.inf.


57840 FRESENII.,JS KABI

600

600

600

10000

10000

10000

8000

8000

8000

Lek

263

I

0,309

0,5155

9.

0,298

0,3024

100

97,!6

98,69

98,1s

100

98,s4

Levor, Solution for infusion, smg/ml -

100 ml, -, Pack: 1

Levor solution for infusion 5mg/ml -

100mlx5

,rxAor{AxH Ar(oPA on. ToMf lM/[roM, x 10

Lidocaine-Tchaikapharma, Solution

for injection, 10 mg/ml-10 ml, mg,

Pack:1

Lidocaine-Tchaikapharma solution forinjection 10 mg/ml-10 mlx 100

100mlsol-inf

5ma/nl l^oml sol.inf.

smg/ml 100m1 sol.inf,

100m1 sol.inf

1% 70ml omp.

t% 10ml amp.

1% 10ml amp.

1% 10ml amp.

I

5,52

Actavis hf

t{al(a+apMa

44960 Bf,cosoxa{,".taixaSapMa

45120 Bhco(oxa

ACCORD-

516,96 5O,lH1,l'{EH nA3A

r.laixa0apMa

545 Btrcoxoxaq

"9aixa$apua552 B[coxoKa

600

ACCORD.

1/trt4,8 EOrIHl,lqEH nA3A

9aixa$apua14il BtrcoxoKaY

,,'.laixa0apMa

7472 Bh.o(o(a

664

A

600

600

800

800

IihAOKAl,lH aMn.

LIDOCAINE

1 OboHrKc OapMa EOOA ,lxaor(AhH cnPEi 10% 38rP

LIDOCAINE

1 Obo8rxc OapMa EOOA

2 Melexc OOA

3 TbproBcKa rtrrc

LIQUID PARAFFIN

1 t'roxrxcLISINOPRIL

1 (Dboxxxc

LOPERAMIDE

1 CooapMa TpeiA{Hr AA2 OboHhKc OapMa EOOA

4

2

LIDOCAINE CHLORHEXIDINE

1 tDuoxrxc Oapma EOOA

2

2

EGIS

PHARMACEUTICAT

90sEGIS

nxAor{AuH AKoPA On.20Mf lMn10MI X 10

Lidocaine-Tchaikapharma, Solution

for injection,20 mg/ml-10 ml, mg,

Pack:1

Lidocaine-Tchaikapharma Solution forinjection 20 mg/ml-lo mlx 100

l{ATE}t(E t+Il,tAOXAhH rE U,5rP X

IXATEII(En rer + rtrAoKatrH x 12.5rp x

2% 70ml qmp.

2%70mlanp.

2% 10ml amp.

2% 10ml amp.

i8d sprov,

389 spray.

5% 40?p uno,

5% 40rp ung.

5%

12,5a oel,

l2,5Egel,

10

LIDOCAINE

L CooapMa TpefiA(xr AA ,lHAONAl.lH yHrB. 5% iu)rp

2 OboHxxc vHrB. 5% 40rP

LIP ASE /AMYLASE/ P ROTEASES

1 OboNf,xc OapMa EOOA ME3HM OOPTE TA6/t, 10000 X 20

KPEOH Kanc. 25000E 300Mr x 20

500ma cops,

500m9 caps.

10000/7500/375U ortobl10000/7500/37sU gr

tabl10000/7s00/37sU ertabl

10O0ml fos.

10mo tobl.

2ma coDs,

2mg caps,

2mg caps.

Pharmaceuticals

EarRaH0apMa

765 TporH AA792 AKTABhC AA

xl.tMARC

Stada Arzniemittel29,8 A

30,24 STADA

1526,4 MONTAVTT

N,4gntavit

1548 Ges,m,b.H.

BERLIN CHEMIE

9,27 MENARI lOO

Abbott Products

18,455 GmbH 5O,2

150

150

150

500

600

500

200

200

200

30

30

90

90

100

100

100

I

5,1

100

LINCOMYCIN

I OboHxxc rDapMa EOOA ,rHHr{oMHqrlH KAnC, 500Mr X 20

227NAPAOI.,IH TE'{EH SOOTP X

AHAPOCTM xatrc, 2mrx 10

AhAPOCTAA KANC.2MI X 10

264

BaxoBThn xanc.2Mr

640 x 4 Powdet for orolsolution

549 x 4 Powder for oralsolution

A4g x 4 Powder for oral

solution

501ma tobl,

500m9 tabl,

500m9 tabl.

1000 a

1000 0,2567

1000 0,2512

38,7 Medochemie

Men Pharma

20,16 AKTABl,IC

BtocoDEx

2106 EEAUTOUR IPSEN

Beaufour lpsen

2130 lndus

SarxaaoapMa-

256,7 AytrH{qa

L-O R N ITH IN E, L-ASPARTATE

L.O RN ITH IN E, L-ASPARTATE

LOSARTAN

1 OboHx(c

LO S ARTAN /HY D ROCLO RTE AZI D

3q orun,

50 10ml omp,

10Mn x 10 10ml

50mo film.tobl.

50mo/l2.5MG

120

120

100

300

300

LYOPHYLLISEO

SACCHAROMYCES

I OboHxx( EHTEPO'I CAIIIETI,I 25OMT X 10

MACROGOL+SODIUM

CHLORIDE+POTASSIUM

CHLORIDE+SODIUM

HYDROGEN

CARBONATE+SODIUM

SULPHATE


600

600

600

1000

1000

1000

200

200

200

200

a

o,2526

a

3,51

MAGNESIUM ASPARTATE

1 CooapMa Tp€lAxHr AA

2

MAGNESIUM OROTAT

I OboHf,xc OapMa EOOA

MAGNESIUM SULPHATE

I OboHrxc rDapMa EOOA

MAN N ITOL NO,N hETUN EH O BA

5W4NKA C ABYNbTEH

MANNITOL CT,6AHKA

MELOXICAM

I MeAooapMa EOOA

2 OboBhxc

MELOXICAM

I MeAexc OOA

2 MeAooapMa EOOA

3 OboHxxc

MEROPENEM

1 MeAooapMa EOOA

2 OboHuxc OapMa EOOA

MESALAZINE

METAMISOL, PITOFENONI

HYDR, FENPIVERINI BR.

MAII{EPOT TAEL 500 Mr X 100

MAfHEPOT 16. 500Mr x 100

Mero[c 16, 15Mr

MOBMI,IC TAEn. 15MT X 10

WOERWAG

252,6 PHARMA

Mauermann

KOPMATHE3l,IH 4OO AMN.

4o95Mr/10Mn X s/KvrXF/

KOPMATHE3HH aMn.400Mr 1oMn x 5

MANNITOt BAXTER l0% Solution

for infusion, 1009/l-500 ml, mB,

400ma 10ml dmp,

400m9 10ml amp.

15% 510ml sol.inf. 2000

75mo tobl,

15mg tabl.

tabl.

15mo/1,5m1 dmp,

15mg/l,Sml amp,

15mg/1,5mlamp.

2625

s09

s0 3,7056

s0 3,42

I0,2581

WOERWAG

185,28 PHARMA

Solupharm

Bieffe Medital

100

90

90

90

2000

2000

2000

23,229 Medochemie

BOEHRINGER

26,028 INGELHEIM

MELBEK, Solutlon for lniection, 15

mg/ 1,5 ml, mt, Packr 1

MeroKc aMn, 15Mr/1,5M,

MoBA,rlhC Alvln. 15Mr/1,5Mn x

I

t,o41,0561

100

98,48

Ho6er OapMa

208 EOOA,6b

211,22 Medochemie

BOEHRINGER

INGELHEIM

15516 Medochemie

15672 FRESENIUS KABI

"9aixa$apua19500 Btr€oKoKa

Mepone +r. ltMEPONEHEM KASh 1fP X 1

Meropenem-Tchaikapharma powder

for solution for injection/lnfusion 1g x

10

1o fl.

rg fl.ls fl.

a7,758

7,836

I

a

4364

a

0,193

100

99

79,t6

cMooMl{ TA6,l, 500Mr x 100

KyTltf,

SPASMOPHARM 500 mg/ml+2mg/ml+0,02 mg/ml solution torlniectlon.Pack: 10

Cl-lA3NllA,Ill-OH aun.2ur x 5

50omq tdbl.

tabl.

2ml omp,

2ml amp.

500/5/0,7mq tobl.

s00/5/0,lms tabl,

400

500

1 Af,acoH2 CodapMa T

s00

500

174,55 EWOPHARMA 1OO

BernpoM AJx,

499 Strraptri510

EarxaH0apMa -19,3 AynHrq 100

BernpoM AA,

2928 Ebrrapx,

METAMISOL, PITOFENONI

HYDR, FENPIVERINI 8R.

I CooapMa TpelArHr AA

METAMIZOLE SODIUM

1 Axacoi

CnA3MMTOH 16, x 20

cnA3MMroH TA6n. X

100

100

100

7a 2ml omp.Metamlzol€ Sodlum VP, Solution forlnlectlon, 500 mg/ml - 2 ml, -, Packl

10 1g 2ml amp.

8000

2 Meaexc OOA

3 cooapMa TpefiAtrHr Aa

Amizolmet, Solution for injection, 500

mg/ml-2 ml, m& Pack: 1

AHMfhH aMn. 1rp 2Mn x 10

AMh3O.4MET AMn. 500MT/M/l 2M/l

1g 2ml amp.

1g 2ml amp.8000

8000

8000

900

900

900

900

3000

3000

3000

0,37

0,38

,4321000 I1000 0,057

1000 0,06

1000 0,075

309

30 4,404

a

72

120

120

UAB Santonika,

2960 AurBa 98,92

3040 CoOapMa M 96,32

VALEANT/PHARMA

3455 SWTSS A4,72

57 UH6xor€x OOA

60 INBIOTECH

SarKaH+apMa -

132,12 XI.iMAKC 100

METAMIZOLE SODIUM

1 Obonf,xc OapMa EOOA

METFORMIN

1 CooapMa TpeiArHr AA2 OboHtrKc OapMa EOOA

METHIL VALERA|E

METHYLERGOMETRINE


4

METAMIZOLE SODIUM

I,'lH6roreq2 OboHhxc OapMa EOOA

3

2

3

2

500mo tobl.

500m8 tabl.

500m9 tabl.

850m0 film.tobl.

850m9 film,tabl.850m9 film.tabl.

film.tabl.

60ma tobl,

tabl.

0,2ma/ml 1ml omp,

0,2m9lml lml amp.

Angetop

AHrfiOn TA6n. 500Mr X 20

nPOMTI4H 16. 500Mr x 20 tabl

50omo/ml-20m1 sol

Al,lMtuH xAnKh 500Mr/Mrl 20 Mrl 500m9/ml-20m1 sol

100

95

76

METOOAHAE16 850Mrx 30

METOO.qilAS TA5I.850MT X 30

Metformin-Tchaikapharmafilm?coated tablet 850mp x 30

16. 6OMr x 20 -

METEPTyH AMn,o,2MrlMI IMI X

100

NOVARTIS

2808 PHARMA 1OO

Novartis Pharma

40,5 Actavis Ltd.;',sarxa41,04 AXTABI4C M

,,'taixa0apMa

Brcoxoxa

51,IN OAPMA

AArOapM EAA,

U850 Srrrapx

11905,2 ADIPHARM LTD

12060 A.AhOAPM EAA

200

200

a

0,04s

0,0456

I

0,936

a

0,89

0,927

100

98,68

METHYLPREDNISOLONE

METHYLPREONISOLONE

METHYLPREDNISOLONE

METHYLPREONISOLONE

METOCLOPRAMIDE

1 MeAexc OOA

2 MeAooapMa EOOA

3 OboHrxc OapMa EOOI

4 CodaoMa TDeiatrHr

METOCLOPRAMIDE

I Co+apMa TpeiArHr A,q

2 OboHrkc

METOPROLOL

1 MeAexc OOA


METEPThH aMn.0,2 Mr

METXInPEAHY3OTOH aMn, 250Mr

250ma omD,

15,78ma omp.

40ma dmp.

725mq dmp.

10mo 2ml omp,

lomg 2ml amp.

10mg 2ml amp.

10mg 2ml amp.

2nl70mo tobl,

l0mg tabl.

1mo/ml sml dmp.

lmg/ml 5ml amp.

1mg,/ml 5ml amp.

+

100

150

8000

iooo

100

99,s4

98,26

MET14, nPEAHH3OIOH aMn.

15.

METhI nPEAHll3orloH aMn. 40Mr+

M ETl4InPEAHh3orlOH aMn.

Degan, Solution for injectlon, 10

mg/2 ml, -, Pack: IErtrraH aMn, 10Mr 2Mr

E II.ITAH AMn, 10Mf/2Mlt X 100

METOCO& Solution for lniection, Img/ml - 5 ml, mg, Pack: I

METOKOP AMN. 1MT/M/] sM,TIX 10

6000

6000

5000

5000

6000

Seqa MeA EOOA,

5340 Etrr 100


5526 MEDOCHEMTE Ltd. 96,63

Lek

5750 Pharmaceuticais

AWD PHARMA

2,952 GMEH & C

38,016

409

/o 0,0738

40 0,9504

3000 3,95

3000 3,9684

3000 4,02

METOPROLOL SUCCINATE

1 OboHrxc

METRONIDAZOLE ECOFLAC


METOHOP aMn lMrlMn 5Mr x

TA5I.47.5MrX 60

MfiPOHllAA3OI O,l.500Mr100M,l

METPOHhAfiOn xHO,p-p x100M, -

ShOOAPM

MIDAZOLAM PANPHARMA, Solutlonfor lnlectlon, 5 mg/ml - 3 ml, -, Pack:

I

MIDAZOLAM PANPHARMA, Solutionfor iniection, 1 mg/ml - 5 ml, -, Packi

50ma tobl.pr.

501ma 700m1 sol.inf.

500m9 100m1 sol.lnf.

100mlsol.inf.

15mo iml omp,

smd sml omp.

401nq tobl./t00mg tabl.

21ma/ml. omp.

TEVA

PHARMACEUTICAI

100

8000 a

8000 1,056 8/T48 FRESENIUS XABI

StroOapM

100

96MIDMOLAM

MIOAZOLAM

MIDECAMYCINE


MORPHINE HYDROCHLORIDE

Rotexmedica

2320 GmbH - P

120

t20120

I0,3533

Rotexm€dlca

-P

42,396 KR(A

MOXONIOINE 0.3 film.tobl.

100

42.672 (RKA d.d.

308

309

1 (DboHxRc MOKCOTAMMA TA5'I.MOXONIDINE

1 CoOapMa TpeiArHr AA MOKCOTEHC 16. 0.4Mrx 30

OboHxkc

M U LT I EN ZY M ES/LI P AS E. P ROT E

ASE ETC,

25000 tu KAnc. xNADROPARIN CALCIUM

1 MeAext OOA

2 OboHtrKc OapMa EOOA

OPAKChnAPIH aMn.unp. 0,4Mr x

NADROPARIN CALCIUM

1 MeAexc OOA


57O0lU 0.6m1 sol.ini. 9000

57001U 0.6m1 sol.ini.

57001U 0.5m1 sol.inj.

0.6m1

O.4mo/ml 1ml omp.

0.4m9/ml lml amp.

50oml sol.inf.

500m1 sol.inf,

500m1 sol.inf.

1s0o g.

1500 0,104

300 L

300 0,0633

300 0,0648

60

12000

12000 2,99

12000 3,0024

12000 3,03

300 A

300 \r2

300 1,356

Aspen Notre Dame

i10850 deASPEN PHARMA

41580 TRADING

Glaxo Wellcome41706 Produ

6Eo0apM

336 l,lxxeBepf,Hr

B.BRAUN

EarEaE0apMa

18,99 AynHrqaAXTABI,,lC

Fraxiparine sol.lni. 9500 antLXa

lU/ml - 0,4 ml, Solution for lniectlon,3800, lU, Pack: IoPAHChnAPhH UinPilq AMn. 0,4M.rl

x10

fllm.tabl.0,4mo film.tdbl.

0,4m9 tllm.tabl.

film.tabl.

30oma coDs.

38001U O.4ml sol.ini.

38001U 0,4m1 sol.ini.

38001U 0.4m1 sol.inj.

WOERWA6

chanelle M€dical;

156 Ro 100

WOERWAG

Aspen Notre Dame

35880 de r00ASPEN PHARMA

36028,8 TRADING 99,59

Glaxo Wellcome

Fraxiparine sol,ini. 9500 anti-Xa

lu/ml - 0,6 ml x 10, Solutlon forlnlectlon, 5700, lU, Packi IoPAHCInAPhH trnPilq AMn. 0,6M,rl

x10

HMOr{COH AMP. 0,4Mr/Mn X

t0htwvql

NALOXONE

1 OboHNxc rDapMa EOOA

N A P RO X E N / ESO M E P R ASO L E

NATRIUM CHLORIDE

NATRIUM CHLORIDE

0,9%+GLUCOSE 5%ECOF4C


NEBIVOLOL

1 CooapMaTpeiArHrAA2 OboHrRc

NEOMYCIN

1 OboHixc OapMa EOOA

2 Co6apMa TpeilxHr AINICERGOLINE

NIMESULIDE

7 UHduomee

2 Co$opMoTpelduHzM3 OboHHKc OapMa EoOA

4,54

4,62

204

20 0,936

100

98,27

3

r,IrcK.5%+HATP.x.,1OP,O,YAAHO,P.

PX500MI nr.EcEPvM mlox03E hHo. P-P 500M,rl

BRAUN 3641216

HESl,lBOrlOrl 16 sMr x 30- AxEBrcHEShBOrOn TA6n.5Mr X 30 AX

5mo tobl.

5mg tabl.

77.72ma/q 320 sprov

l,",72frglg 328 spray

POTTA

78,24 TARCHOMIN

TarchominHEOMXlll.rHvM TC CnPEF 32rP

15. 10mr r 90

Biolin

6UO0UH m6. 100Me x 30

EHETPA TA6/I,1OOMT X 10

AllDone effervescent tablet 100mg x

1

l1mo tobl.

tabl.7OO ma tqbl.

10O mg tdbl.10O nq tobl.100 mg tabl.

100 mE tabl.

10ma 50 ml sol,inf,

10mg 50 ml sol.inf.

30mo film tdbl.

30mgfilm tabl.film tabl.

l1oul/ml3ml fl.

201ma tobl.

200m8 tabl.

1000 a1000 0,2597

a

7,2336

Pharmaceut

SarxaHoapMa -

207,9 oopMoM255,23 UHEUOTEXOOA

281,88 ARTABhC M"9aixaOapMa

Btrcoxoxa

1674 Bayer Pharma AG

259,7 Bayer Pharma AG

99,4 Medochemie Ltd.

I54,08 ZENTIVA

EU UtLt & ETANCO

72,336 G

L11,16

10

10

10

75

150

150

150

10

10

200

200

200

a

7,824

7.94

I0,237

0,29470,3132

I0,497

0,7704

900

900

900

900

900

700

78,38

73,7s

38,55

NIMODIPINE

1 CoOapMa TpeiA{flr AA HHMOTOn S Or. 10Mr/50Mr x 1

HhMOTOn S hHO.P-P 10Mr/50Mn50M,n x 12 OboHhxc

NIMODIPINE

1 CoOapMa TpeiAxxr AA HhMOTOn S 16. 30Mr x 100

NPH INSULIN (ISOPHANE

INSULIN) (qOBEWKU,

CYCN E H',14 P AH, CbC CP EAH A

NPOAb]TKUTENHOCT HA

AEilCTBUE)

OFLOXACIN

1 CooapMa TpefiAxHr AA

2 OboHxxc

OLENDOMICIN /DEXAMETAZONE /

OMEPRAZOLE

MEAOOTOKCXH 16. 200Mr x l0

20ma cops,

1 1,186{orec

2 OboHhKc OapMa EOOA

3 MeAeKc OOA

TpeiaxHr AA

OMEPRMOLE

OMEPRMOLE

I MeAexc OOA

ONDANSTERON

I OboH{xc OapMa EOOA

2 MeAexc OOA

Bioprazol

6honPA30/t KAnc. 20Mr x 28

Omeprazid, Gastro?re5lstant capsule,

hard, 20 mg, -, Pack: 14

OHAAHCETPOH AKOPA O,|,2MrlM/t 4MI X 10

20mg caps,

20mg qaps.

20mg ca!s.

20ma modif. tdbl.

2omg modif. tabl.

20mg modif. tabl,

modif- tabl

slu/ml lml onp.

slu/ml 1ml amp.

40ma tobl,

tillmg tabl.

21mo/ml 1ml omp.

lml500ma tqbl.

500m9 tabl.

500mg tabl.

tabl

80ma suDp,

80mg supp.

150ma supp,

150mg supp.

supp.

300mo supp.

300m9 supp.

120mo/5ml-70Oml

:cra120m9/5ml-100m1

10 mo/ml 700m1 omp

10 mg/ml 100m1 amp

40mo fl

tl0mgfl

Lek

2380 Pharmaceuticals 100

87,78 1,186{orex OOA

89,838 tNBtOTECH

Ho6ea Oapma

96,6 EOOA 6b

104,538 SC Zentiva SA

31,6 Manu

LAEORATOIRIES

LABORATOIRIES

188,1 PFIZER HOSPITAL

Pfizer

420

420

420

420

0,209

0,2139

o,23

0,2489

a

0,9024

L

o,197

r0097,71

90,87

83,97

100

88,48

20Mr x 28

40ma fl.

Probitor, Powder for concentrate forsolutlon foi

40mo / 70 ml. Powd.

!!L

Probltor, Powder for concentrate for 40mg / 10 ml. Powd,

solution for infusion, tlo, m& Pack: I lnf,40mg / 10 ml. Powd.

COnPM aMn.40Mrx 5 lnf.

2mo/ml omp

2mglml amp

Zofran, Solution for injection, 2

mg/ml - 4 ml, -, Pack: 1 2mglml amp

4Mrx10-

ioomd film-coot.tqbl, 600

TEBMENThH 3OO MT Oll,M. TA6'I

28 Pharmaceutlcal 100

31,24 Actavis hf 89,63

24 G,L.PHARMA GMBH 84,24

1804,8 GEDEON RICHTER

Gedeon Richter Plc

28,322 KRKA d,d,

NOBEL PHARMA

1860 l,lB6xorex OOA 100

1980 |NB|OTECH 93,94

I.ABORATOIRIES

1200

1000

1000 234

1000 2,4

204

20 1,398

20 1,58

20 7,79

100 I

100 0,28

100 03124

ACCORD-

27,96 6OrHhqEH nA3A

GlaxoSmithKline

3

2

2

OXCARBAZEPINE

oxYcoooNE

I MeAexc OOA

2 CooapMa TpefiAxHr M

3 OboHu(c

oxYroaN

1 OboExxc OapMa EOOA

PANTOPRAZOLE

1 CooapMa TpeiArH. AAOboHBkc

PAPAVERINE

PARACETAMOL

1l.lH6{orer

2 OboHrKc OapMa EOoA

PARACETAMOL

1 CooapMa TpeiAxHr AA2 OboHxxc

PARACETAMOL

1 CooapMa Tp€iAxHr AA

2 (DboHrkc

PARACETAMOL

1 CoOapMa TpeiAnHr AA

OxYCONTIN, Modilied release

tablet, 20, m& Pack: 50

oxchl(oAOH AXTABI4CT6 c y.o.2oMt

x50

oKct4/lAH TAEI. 20Mr X 50

oxcxrotll,rH AMn. 5ru /lMn xsltlvr|,,fil

aMn.5lU 1Mr x 5

x

HOInA3A1640Mrx30nv/lcET TAE/|. 40MT X 28

2000

2000

2000

336

ji7

12OO O

1200 0,6s

140 A140 0,2023

a

0,424t.4272

I

1,08

nAnABEPHH aMn.

Paracetamol lnblotech

nAPAt-lErAMO/t rAE.n. 5ooMf X 20

INBIOTECH

nAPAUETAMOTI 16. 500Mr x 20 -

EOEPMfAH cytr03, 150Mr x 10

EOEPMTAH CYN. 15OMTX 10

nAHAAO, EEEE cxp. 120Mr/5Mr

100M,

nAPAqETAMOI On, 10Mr/M,l100M, x 1

nAPAUETAMOI Or 10 MrlMr 100 Mr54 TRESENIUS XABI

65,5 B. Braun Meidacal 5

30000 a30000 0,062

30000 0,065

30000 0,073

724

120 A

120 0,36

!20 0,3648

15

15

a

t2,54

100

92,73

100

96,46

60

60

50

6060

120

120 696 Farmaclair 100

50

50

50

200

200

200

PARACETAMOL

PARACETAMOL

1 OboHxtrc OapMa EOOA

PARACETAMOL

nonhETnnEHoBA qyrunxA c

PARECOXIB SODIUM


PENICILINUM

CRYSTALLISATUM TZF

1 CooapMaTpeiA{BrAA

AXHACTAT On. 40Mr 2Mrl+PA3TB.

xtl,/yT,/,BlAhHACTAT cyxa aMn. 40Mr + pasrB.

nEHnqhrll,lH xprnTZF 0r. 1000000

IU

ft 3

100O0OO lU pow

1000000 lU pow

o

2,76

2,8081 000 000 0.n. 1000000

PENICILINUM

CRYSTALLISATUM fZF


2 OboHxxc

PENTOXIFYLLINE

I MeAexc OOA

2 CoOapMa Tpe;ArHr M

3 <Duoeqxc

PERINOOPRIL AR6ININE /

PETHIDINE

PHENOBARBIfAL

PHYTOMENADIONE

t CooapMa TpelAxHr AA

2 OboHUx(

PIPECURONIUM BROMIDE

1 CooapMaTpeiAxHrAA2 (DboHhxc

1 MeAexc OOA

2 OboHr(c

PIRACE|AM

I OboHrxc OapMa EOOA

POTASSIUM

CITRATE/.POTASSIUM

5000000 lU pow

5OO0OOO lU pow

5000000 tu

100mo 5ml omp,

100m9 5ml amp,

100mg 5ml amp.

Tarchomin

1194 Pharmaceut

1212 POLFA TARCHOMIN

nEHxqxIrH rZt 0r. 5000000 lU

5 000 000 0I.

PENTlLlN, Solstion forlniection/infusion, 20 mg/ml - 5 ml,

mg, Packr 1

nEHTOOt/,nhH aMn.100Mr/5M, x 10

nEHTt4/thH AMn. 100Mr sM/t X

200

200

200

300

300

300

300

I

5,97

100

94

0,47

0,5

I

10,8

.968

100

100

800

800

800

OEHOEAPEI4TA,| Na aMn.

200Mr/2Mr x 10

201ma 2ml omp.

10mq 1ml omp.

10mg 1ml amp.

ml

4mo+solv 2ml omD.

4mg+solv 2ml amp.

4o/0.5o - Sonl fl. 150

4sl0,5s - 50ml fl.

KR(A, d.d. Novo

l4l Mest

150 cooapMa Aq

KRKA

Pou Strrapxi294,4 EOOA

F-HOFFMANN-LA

Panpharma

862,5 Laboratorl

883,8 FRESENIUS KABI

5ml

5ma/1,25mo/10ma

2,5ma/0,625ma

50mo/ml-2ml qmp351

352

150

150

KOHAKhOH MM aMn. 10Mr lMr x 5

KOHAX14OH AMN,lOMT/MI 1MN X 5

400 I

400 0,736

400 0,144

200

200

800

800

800

I

2,92

2,92A

2336 Gedeon Rlchter Plc.

2342,4 GEDEON RICHTER

APAYAH aMn,cyxa 4w I 2Mn x 25

AMn, 2M/t X 25

Piperacllln Tazobactam Panpharma,

Powderfor solution for lnjectlon, 4g/500 mg, g, Pack: 1

nhnEPAuInr{HrrA3o6AKTAM XAsh5,751s0

150

100

97,59

ACID

1 (DboHrxc

PUSCO

1 OboBrKc

POTASSIUM CHLORIDE MINI

HOOTPOnXT AMn.3rPll5Mr X

t2lRWy.AlHooTPonhrl aMn. 3rc| ls[, !5M, x

t{A,lt1HOP EOO. TAM. X 15

KA.,l],IYM X'OPATYM AMN. 14.9%

CA1IIETA X 6

vHrB. 10% 100r 10%200

- 50ml fl.iq 15ml omp.

3g 15ml amp,

15ml

2.17a/2o/2,057

eff.tdbl.

2,t7Elztl2,057eff.tabl.150mq/ml loml omp.

mini - plosco

150m&/ml 10ml amp.

UNION CHIMIQUE

15168 EELGE

15200 UCB Pharma SA

16000

16000

16000

iooo

3000

4000

40oo

a

0,948

POTASSIUM

CHLORIDE+SODIUM

CHLORIDE+SODIUM

HYDROGEN

70% TOOml sol.

10% 100m1 sol,

1920 DEZMA GmbH 100

S.BRAUN

B.BRAUN

864 Bera OapMa AA

877.M XI4MARC

765,8 Bera OapMa AA 100

X14MAXC

C A R B O N ATE+ M AC RO GO L 3 3 50

1 (DboHrxc

POVIDONElODINE

1 OboHxKc

POVIDONE.IODINE

L CoOapMa Tp€iAxHrAA2 OboHilxc

POVIDONElODINE

I CooapMaTpefiArHrAA2 OboarKc

364 POVIDONE-IODINE

355 PRAZOSIN

356)Npedui PRENOXIDIAZ|NE

L OboHrKc OapMa EOOA

PROGESTERON

I OboHrxc OapMa EOOA

ioAAAEPM p-p 10% lOOOMr. Er

nPA3O3HH 16, 2Mr x 50

52,5x5Powderfororol solution

52,5 x 6 Powderfororal solution

10% 200 s. una.

10% 7o11ml sol.

10% 1000m1 sol.

240

80

80

80

400

400

100100

900

900

3OO A300 2,s56300 2,456

10% 9Oo und.

L0%

2mo tobl,

tabl.l11ma tobl.

100m9 tabl.

tabl.10Omo cops.

100m8 caps.

336 SANOfl AVENTTS

Chinoin336 Pharmaceutlc

a0,42,u6EKChH TA5I. 100Mr X 20

,ltlSEI{Cl,lH 16. 100Mr x 20

I

0,4232

EKOOAPM TPYN

380,88 EOOAyTPOTECTAH RAnC. l00Mr X 30

PROMETHAZINE

HYDROCHLORIDE

PROPAFENONE

1 OboHrtrc rDapMa EOOA

AHTIATEP3I.lH aMn.

25mo/ml 2ml amp.

2ml

300mo film.tqbl.

300m9 fllm.tabl.

film,tabl.

3,smq/ml 10ml omp.

lomq/ml 20ml omp.

50oma 50ml fl.

20ma film.tdbl.

20mg film.tabl.

film.tabl.

50 ma tobl.

50 mg tabl,

50 ms tabl

lOmq/ml-5ml omp

2oo/13,8a/nl - 200 ml

3, 80 /1 3 o /3.4a /1. 5 a /m I

300

300 0,2454

300

50

50

800

800

500

500

389

2

2

2

PROPAFENONE

PROPOFOL

1 OboBf,xc

PROPOFOL

I OboHxxc

PROPRANOLOL

I CooapMaTpeiA{HrAA

2 O6oHrxc

PROPYLTHIOURACIL


PROTAMINI SULFAS

P R OT E N I S /CARBO HY D RATES /F

P R OTE N I S /CA R BO H YD RATES /F

PROXYMETACINE

1 OboHxxc

PYRIDOSTIGMINE


PYRIDOXINE

RABEPRMOLE SOLDIUM

1 CooapMaTpefiAxHrAA

2 Vl{6uorec

RACECADOTRIL


PTITMOKAPA aMtr, 3,Smr/ma 10ma x

50

PI,ITMOHOPM TAE,I. 3OOMT X 20

PhTMOHOPM 16. 3OOMr x 20

nPonooo,l AMn,l% 20MrlIRESENIUS

nPonooo,l o,l.1% 50MIFRESENIUS

73,52 MYTAN r00Abbvie Deutschland

G

2500

2500

nPOnPAHOIOI 16. 20Mrx 50 -

Aynxxqa

nPonPAHOIO/l TAE/I. 20Mr X 50 AK

nPonHqrr TAE,I, soMrx 100

16.50Mrx 100

nPOTAMHH ME aMtr. 10001E/ml

5Md 5

r{AflhMl,lH AP. 60Mr X 100

KArll4Ml4H 16. 60Mr x 100

8}lTAMl.lH B 6 aMtr

AqHrECOr 161 20 Mrx 14

Rabioxin

xxAPACEK CA1UETA 10Mr X 16/3A

KbPMA'{ETA/

XI,IAPACEK caue 10Mr x 15 - 3a

200 I

200 0,0432

200 0,0437

150

150 0,t782

150 0.7797

300 0,6924

300 0,1002

SarKaH0apMa -8,64 Pa3rpa

8,74 AKTABhC A.q

100

98,86

604

50 10,5

ADMEDA

25,73 ARZNE|MITTEL 100

Haupt Pharma

26,865 Berlin 99,5

Tarchomln

3.8a/1io/3.4a/ml -

5mq/ml - 15ml eve

0,5% 15ml drops eve 15

50mo tobl. 300

60mg tabl.

ALCON

117 PHARMACETICALS

tabl.

s1mo/ml 2ml omp,

20md film.tobl.

20mg tilm.tabl.

film.tabl.

TOmo pulv,

10mt pulv,

700 a

700 0,2971

700 0,44a6

309

30 1,25

604

60 0,9885

60790490 0,0393

90 0,1113

TEVA

PHARMACEUTICAL

207,72 S 100

AWD PHARMA

actavis ehf.;

207,97 Eanxax

Laboratorios

314,02 Liconsa

100

s9,31 MY|"AN 100

Laboratoires

3,537 Merckle GmbH 100

10.017 Medochemie 35.31

RAMIPRIL

1 CooapMaTpeiAxHrAA PAM}lnPllrl TEBA 10mrx 306p

PaMxMeAT6. loMr

10ma tobl,

10m8 tabl.tabl

10llJ/10m1 powd.inf.

10lU/10m1 powd,inf.

10lU/10m1

RETEPLASE

1 CooapMaTpeiAxHrAA

2 OboHxKc

ERGOALqFEROL 4OOIU

RILMENIDIN

RIVAROXABAN

1 rDboHxxc OapMa EOOA

2 CoOapMa

RIVAROXABAN

I OboHxxc Oapma EOOA

PAnHIHCI.IH aMtr.10lU +pa3B.loma x 2

PAnh.n[3hH o.n. 10tu x 2

L9

t 797,69

1 810

150

569

56 3,9416

56 4,3857

797,69 Cenexi

TEVA SPECIALTY

810 PRODU

78q uno.

lmo tobl,

75ma film tobl

KCAPE ITO OXllM.TAErl. 15Mr X 28 15mg film tablKCAPE ITO 16. 15Mrr 28 15ms film tabl

20 mo film tobl

XCAPE ITO OllnM.TAEn, 20Mr X 28 20 mg tilm tabl

I200

200

280 A

280 3,93

Delpharm Bretlgnl

14,505 Fr

1100,4 SAYER

220,7296 BAYER

390

2 l(CAPEnTo 16. 20Mr x 28 20 m! film tabl Pharma AG

100

R O 5U VASTATI N'I M A APY T'4

SACCHARATED IRON OXIDE

1 CooapMaTpelAx8rAA

2 OboHrxc

SACCH ARO M YCES B O U LAR D I I

I Co+apMa TpeiArHrA.q2 OboHrHc

SALBUTAMOL

I Co+apMa TpeiArHr AA2 OboH{xc

SALBUTAMOL SULFATE

I CoSapMa TpeiAxHr AA

2 OboHhxc

SALBUTAMOL SULFATE

1 CooapMa Tpef,ArHr AA

SEVOFLURANE

1 CoOapua Tpeiarxr AA

2 (DboHrxc

sILVER SULFADIAZINE

1 OboHx(c rDapMa EOOA

SILYMARIN

SITAGLIBTINE / METFORMINE

SOOIUM BROMIDE

SODIUM CHLORIDE

1 oboHxxc oapMa iooA

2 CodapMa IDei[HHr All

I,IAAOEP aMn, 100Mr 5M, x 5

70omo sml omp.

100m9 5ml amp,

con.2oMr/Mn 5M/l x 5 100mc 5ml amp.

250mo soch,

250m9 sach.

sach.

2ma tobl.

2mg tabl.

tabl

sma/ml 20mlfl.

5mg/ml 20ml fl.

EHTEPOTI naxefle 250Mrx 10

EHTEPO.n CAfllETh 250MfX 10

CMEYTAMOTI 16. 2ilr x 30 - Ciech

cMSvTAMO,fl TAEn. 2Nrr X 30

BEHTOTIhH p-p sMr/Mr x 20u

BEHTO.nhH CO.n.sMf lMn 20Mn

CMEYTAMOTI aepGor100Mxr/10M, x 200Ao3,

Buto-Asma Pressurised inhalation,

suspension 0,1 m&/dose - 200 doses x

1

cMSyTAMOn AEPO30/t 100

20ml fl.

100moc 2oodos fl.

100mgc 200dos fl.

20

20

20

90

90

90

100

100

100

900

900

50

50

50

2000

2000

a0,869

a

0,0873

aL2,64

12,672

206,8

200 a

200 9,19

200 9,35

so1 I

500 3,41

500

500

2000 a

2000 \,2s

509

s0 o26t

252,8 VIFOR tranceVIFOR

253,44 INTERNATIONAI.

43,45 BTOCOOEX

BlocoDEx

Warsaw

7,857 Pharmaceutica

28 POLPHARMA

Glaxo wellcome1838 Opera

GLAXO SMITH

1872 KLINE

Glaxo wellcome1715 Produ

"9aixaOapMa

1770 Bxco(o(a

rrlAXCO CMl,1T

7776 RIAIH

Aesica

1034 Qu€enborough

8 ABBVIE EOOD

814,8 SANDOZ

Salutas PharmE

820 GmbH

B.BRAUN

13,05 METSUNGEN

35

100mgc 200dos fl

200dos fl

CESOPAH 0r. 250Mr x I

CEBOPAH OI. 250M/l X 1

AEPMA31'!H KPEM 1% 50rP

10ma/o soa ctem.

10mg/g 509 crem.

90mo coDs,

t(APCI{r'l xanc. gOMr x 30 -

100ma/ml 5ml amp.

HATPHYM SPOMAryM aMf,.

0,9% 10ml omp, mini -

plosco

HATPIEB )(,OPTIA AMn. loMrl x 20 0,9% 10m1 amp. mlnl -

plasco

0,9% 10ml amp. mini .

20% 70ml omp. mini -

0.9% lOOOml sol.inf. 200

HATPhEB X,lOPhA hHO.P-P 0,9% ln3&7202 l000ml sol.lnf.

0.9% 250m1 sol.inf.

HATPUEA X/]OP},,A },HO,P -P 0,9/6

25oml fl someopeuo

cucmeuo 6eE

oAonmoD

250m1 fl 3aBopeHa

crrema 6er a4anrop

250m1 fl 3arBopeHa

100

100a

8,148

I

o,2433

8.BRAUN 3641147

HATPI,IYM x,lOPAryM aMn.

SOOIUM CHLORIDE LDPE

ECOFLAC

SODIUM CHLORIDE - LDPE

ECOFLAC

E.BRAUN

2150 MELSUNGEN

SODIUM CHLORIDE 8,6 /POTASIUM CHLORIDE O.J

SOOIUM CHLORIDE

8. 5G /P OTAS 5 I U M CH LO RI D E

0.36/CALCIUM CHLORIDE

O.J3G B lL NONUETUNEHOBA

SWUNKA C IIBYNbTEH

SODIUM CHLORIOE

8, 5G /P OTAS S I U M CHLO R I D E

0,36/CALCIUM CHLORIOE

O,3JG B 1L NONUETqNEHOBA

6yTt4nxA c.0.BynbTEH

SODIUM CHLORIDE

8. 5G /P OTAS S I U M CH LO RI D E

O.JG/CALCIUM CHLORIDE

O,JJG 8 lL CT. SAHKA

SODIUM CHLORIDE

fionuErunEHoBA no6YfhNKA C ABYNbTEH

CTEP14NEH NOPT

1 OboH{xc

SOOIUM CHLORIDE

NONU ETI4]IE HOBA 6WnNKA

C ABYNbTEH CTEPUNEH NOPT

Ringer Baxter, Solution for infusion,

o.33 sl 0.3 El 8.5 sll - s00 ml, ml,

Pa.k: 1

5o0ml sol.inf.

500m1 sol.lnf.

2000

ECOFLAC

I lDboHxxc

SOOIUM CHLORIDE CAK

SODIUM CHLORIDE CT, EAHKA

SODIUM HYDRAGEN

CARBONATE

L OboEx(c rDapMa EOOA

HATPXEB MOPHA HHO.P-P 0,9%

100MI B,8RAUN /t46745

HATPtlEB X,OPXA XHO.P-P 0,9%

5OOM'I B.8RAUN

HATP.x,|OPIA rH0.p-p 0,99{

Sodlum Chlorlde Eaxter 0,9/6 ,

Solution for infusion, 9g/l - 500 ml,

Pack: 1

Sodlum Chlorld Baxter 0,996,

Solution for infusion, 9mg/ml - 100

Pack: I

x5

KOHBYTEKC aMn.

T-PA fiOA 5% loooMr X

ThHXTPA

KIlCrOPOAHA BOAA 3% 1000mr -

BT

ETU/IOS CnUPf 70% x1000Mr BT

EThnoB 70% il /0.800N, x

ETHTOB Cni4PT 90% 1000M^ - BT

ETl.lrlOB CnHPT 95% 1000Mr - BT

CNhPT

0,9% 500m1 sol.inf. 2000

0.9% so1ml sol.inf. 10000

0.9% 70oml sol.inf. 5000

8.4% 20 ml. dmp.

0.9% 100m1 sol.inf,

0,9% sooml sol.inf.

8,4% 20 ml. amp

20 ml,

100md/1ml dmp.

15000 I

15000 0,888

60000 a

60000 1,116

8.BRAUN

13320 MELSUNGEN

8ieffe Medital

B.BRAUN

6xo0apM

Bieffe Medital

Bleffe Medital

HATP],IE8 El,IKAPSOHAT AMN.8,4%

20Mnx58RAUN3641195HATPhEB 514(APEOHAT aMn. 8.4%

B.BRAUN

20735 MEtSUNGEN

B. Brown

3000

3000

3000

1800

1800

1800

1800

6,912

2 7

SODIUM VALPROATE

SOL, ]ODI SPIRITUOSA

1 Oboixxc OapMa EOOA

SOL,HYOROGENIUM

PEROXYOATUM

1 CoQapua Tpei4rxr A,Q,

2 OhoHr(c

SOTALOL


SPIRONOLACTONE

I CooapMa Tpef,ArHr AA

2 OboBxKc OapMa EOOA

SPIRONOLACTONE

SP I RTUS AETHYLICS 7O%VN


OhoHrkc

SPI RTUS AETHYLICS gO%VN

I CoOapMa Tp€iA{xr AA

2 OboHrKc

SPIRTUS AETHYLICS 95%VNI CooapMaTpeiMHrAA

2 OboHtrxc

SUCSAM ETHO N IU M CHLORI DE

1 (DboHrxa

50

50

3.93 17,004

160md tobl.

COTAXEKCM TAEn. 160Mr x 20 150m9 tabl,

COTAXEKCM 16. 160Mr x 20

25ma film.tobl.

CnUPOHOTIAXTOH 16. 25Mr x 30 -

AxEBxc 2smtfilm.tabl,

CnhPOHO/IAKTOH AP. 25Mr X 30 AK 25mg film.tabl.

Spironolacton-Tchaikapharma

film?coated tablet 25 mE x 30

50ma film.tqbl.

Splronolacton-Tchalkapharma

fllm?coated tablct 50 mc x 30 film.tabl.

3% 1000m1 sol,

3% 1000m1 sol.

70o0ml.5ol.

1000m1, sol.

1000m1. sol.

7000n1. sol.

1000m1. sol.

1000m1. sol.

209

20 2,52

20 2,568

so950 0,207

50 0,209

50,4 BeE OapMa AA

10,3s SANDOZ

Salutas Pharma

10,45 GmbH:

Sarxaa0apMa -138,06 AynHrq

140,4 AKTABhC AA

"tlafiKaOapMa

100

99,04

I

0,o767

0,078

100

98,33

1800

1800

172.8 Brcokoxa

"t{aiKaoapMaBrcoKoxa 100

2908,8 Bera OapMa AA 100

3168 BeB OapMa AA

800 a800 3,636

800

800

800

800

800

800

a3,96

.704

1009nl, sol,

1000m1. sol.a

3,996

, sol.

7%-5ml dmp.

1%-5ml

a

SUFASALAZINE

,ll.lcTEHOH AMn. 1% sMn X

500mo tdbl.

600

2,5056

I OboHrlc OapMa EOOA

cy,loAcMA3lll{ EN TAEI.s00Mr X

50 500m9 tabl.

tabl

Soma/ml+76mo/ml

Sml omp.

80mg/ml+16mgilml

5ml amp.

80m&/ml+16m9,/ml

5ml amp,

80m&/ml+16m9/ml

5ml

1% 5ml omp.

1% 5ml amp.

1% sml amp.

L%snl80ma tobl,

80mt tabl.

tabl

80/12.5mo tobl.

80/t2,5nq tobl,80/12,5m9 tabl.

80/12,5ms tabl.

80/25na tobl.

80/25mg tabl.80/25ms tabl

O,2ma 2ml omp.

0,2m9 2ml amp,

2ml

40lU 0.5m1 omp.

40lU 0,5mlamp.

40lu

300mo tobl.

5mq tobl,

5m8 tabl.

tabl

501mq 7ml omp,

1ml

2ml omp.

2ml amp.

2ml amp.

2ml

15/70/0,O2ma coottdb.

15/10/0,02m9 coattab.

200 0,2038

200 0,2048SULFAMETHOXAZOLE +

TRIMETOPRIM

I MeAeRc OOA

2 CooapMa TpeiAtrHr AA

3 OboHxxc

SULFAMETHOXAZOLE +

TRIMETOPRIM

I OboBxxc OapMa EOOA

CY,NOACA,NA3hH 15. 500Mr x

Biseptol, Concentrate for solutlonfor lnfuslon, 8omt/ml + 15mt/ml -sml, m& Pack:1

ShCEnTOn aMn 80Mr/ut + !6ur/nt

2

2

3

2

2

200

200

200

200

1,89

L,97

100

98,95

100

99,67

98,6s

SUXAMETHONIUM


2 AAa.oH

3 CoOapMa

TELMISARTAN


TELMISARTAN /HYDROCHLORTHIMIDE

7 Obuuxcodp$oEOOA2 ly'H6troreq

,,II,ICTEHOH AMN. 1% sM'I X

5/OnAKOEr{A/

LYSTHENON, Solution for injection, 10

mg/ml - 5 ml, mg, Pack:5

,nhCTEHOH aMn. 1% 5 Mr x 5

AKTE'ICAP TA5'I. 8OMT X 30

Telsart tablet 80 ms x 28

Nff E1CAP H CT TA 6n. 80M rft 2. sMt

400ma/80ma tobl.

SUCEnTO, TA5rl. 400Mr/80Mr X 28 /O0mg/80m8 tabl.

CYMETPOnilM 16. 480Mr x 20

5M, x 10

6hcEnTon

x28Telsol Plus

Co-Telsart tabl

METh3O.|I TA5'. 5MT X 50

METl43On 16. sMr x 50

MU.,ITAMMANKANC.XlOO

BhTAMhH B KOMn.nEXC aMn. 2Mr x

10

14,14 Polfa LTD. 100

EGIS

Pharmaceuticals

I

0,1414

1605

2so0 a

2500 2,5055

2500 2,514

2500 2,54

550 L

560 0,109i550 0,2204

560 0,2539

5264 TAKEDA

Takeda Austria

6285 GmbH,

Takeda Austria

6350 GmbH

5,712 AlfiABttc AA"9aixadapuaBvcoxoxa

61"208 AK|ABUCML23,424 VtH6vorcx OOA

"9ailxa{apua184 BxcoxoKa

100

100

100

56

56

56

280

280

280

30

30

30

900

900

900

a0,to2

t.2674

TELMISARTAN /HYDROCHLORTHIAZIDE

1 Obo8xxc OapMa EOOA

2 ly'H6xorec

TERLIPRESSIN


2 OboHxxc

TETANUS |OXOID

1 OboHr8c OapMa EOOA

AI{TETCAP HCT TAE t. 80Mr/25Mr X

28

Telsol Plus

PEMECTIn aMn.0.2Mr/2M^ x 5

PEMECThN AMN. O,2MT 2MN X

TETAHUT{EH TOKCOXA AMn,0,5/1

AO3A X10/KyT11r/

TETATOKC aMn.0.5M, x 10

I

6,8

a

0,117

iln49,59

43,0s

100

98,36

2525

a

1,0488

I

0,335r

7,47

943,92 Eyn EUO-Hr.pnE 100

Ey,I Srlo-Hu3nE

440

441

THEOPHYLLINE

THIAMAZOLE

1 OboHrx€ OapMa EOOA

THIAMINE

THIAMINE HYDROCHLORIDE

/PYRIDOXINE/

CYANOCOBALAMIN /LIOOCAINE

I MeAe(c OOA


1

1s0 I150 0,052

50

50 0,048

20

600

500 t,E

600 1,3055

500 r,37

MEDA

PHARMACEUTICAI.

2,4 S

MEDA Pharma

BrlTAMl,lH B 1 aMn.

Nelraxln 8, Solution for lnlectlon,100 mgl100 m8/l mgl20 nglzml, -,

Pack: 1.

Mh,]TAMMA N AMN. 2M,fl X

slt<YfvlA/

N aMn.2Mr x 5

AS KALCEKS,

774 ,afiuaWOERWAG

783,36 PHARMA

solupharm

822 Pharmazeut

100

98,81

THIAMINE NIIRATE

/CYANOCOBALAMIN/

P YR I D OXI N E HY D RO C H LO R I D E

1 Obosxxc OapMa EOOA

1500

1500WOERWAG

50415 PHARMA

2715

THYM I E XTR,+ P LAN TAG I N I S

EXTR,

7.53q/7,53o/100a

svrup-125m1 sir

1,s3Ll7,s3Ehool

6OOma 50ml sol.inf.

600m9 50ml sol.lnf.

50oma 24ml sol.inf.

6wmg 24ml sol.inl.

24ml sol.inf

2mq tabl,

2mg tabl.

1000 I

ilno 7,5

30

30

1000

1000

144 DENTINOX BERTIN 1OO

TlocTlc ActD


TtocTlc AclD

1 Medexcool,

TUOTAMMA ryPEOCET AMN,

600Mr/50M/t x sTT4OTAMA ryPEO-CET 0r. 600Mr

fhloctqcld 6U) f, Solutioo lotlnjectlon,6(N, mq/24 ml, Pdck: 7

s000 9.

5000 9,2904

5000 9,35

6000

6000 0,0974

6000 0,118

I

2,748

2,8

WOERWAG

46452 PHARMA

solupharm GmbH&

46800 Co

TEVA

PHARMACEUTICAI.

584,4 S

Niche Generics

100

99,26

2 Obo8rKc OapMa EOOA ThoKrAul4n AMn. 500Mr 24Mll x 5 600mg 24ml sol.inf.

Medo Phomo7500 GmhH ond 7(n

MEDA

9552 PHARMACEUTICALS

Meda Pharma

9720 GmbH and

78,52

3 ThOKTAUI4I 600 T aMn.24M, x 5

TIZANIDINE

1 OboHrxc OapMa EOOA TI13AH1,iA11H TEBA TA5I. 2Mr X 50

7

r00

2

TOBRAMYCIN

TOEPEKC xanKr 3a oqr 3mr/mr

TO B RAM YC I N + O EXAM ETAZO N

TOLPERISONE

1 CoOapMa Tp€lAxHr AA MIAOKMMAp. 150Mrx30-

TOBPAAET{C l(O/rHP 5M,l

xanKt 3a oqx sMr -

1 OboHf,xc OapMa EOOA T06PAAEt{C vHr8. OOT. 3,5rP

0,3% 5ml drcps eve 10

sml dtoDs eye

5ml drops eye

3mo/1mo/o 3.5a

oint.eve

3mEhmglgS.sgoint.eye

3mE/!mE/93.59

150md film.tobl.

150m9 film.tabl.

50Mf x 30 film.tabl.

70mo 2ml, omp.

10mg 2ml. amp.

ALCON

13,896 PHARMACETICALS 1OO

S.A Alcon Couvreur

14,1 N 98,55

105 Gedeon Richter Plc.

GEDEON RICHTER

BERTIN CHEMIE

931,2 MENART

A Menarini

Manufactu

8ERIIN CHEMIE

377,28 MENARI 100

A Menarini

at-coN13,74 PHARMACETICAI.S

S.A Alcon Couvreur

14N

100

3 4,632

3 4,1

TORASEMIDE

1 OboHnxc OapMa EOOA

TPXOAC AMn.l0Mr/2Mn X s

TPhOAC aMn. 10Mr/2M, x 5

TPHOAC AMn. 20Mr/4Mn X 5

TPI4OAC aMn. 20Mr/4M, x 5

TOPCI.iT SR TAEn. sMr X 30

TPI4OAC l{oo 15. sMr x 30

TA5I. 200Mr X 30

TPAMMfhH aMtr. 50nrl nn 2nt x

10

TPAMAAOI AMn. 100Mr 2Mn X

Doreto, Film coqted toblet, 37,5m9/325m9, -, Pock: 60nAPATPAMOn TA6n .37.51325Mt X

30

nAPATPAMO,tI ra61 37.sMr/3?5Mr \

TORASEMIDE


2

2

3

2

TROXERUTIN

I Af,acoa

a

0,t75

76

200 L

200 1,8864

200 7,92

1000 I

1000 0,93t2

1000 0,95

2omo 4ml. omp.

20mg 4ml. amp,

smo tobl,

5mg tabl,

tabl.

200md tobl.

tabl.looma 2ml omp,

100mg 2ml amp.

2ml

37,snd /325mdfilm.tobl.

37,5nq /325m9film.tobl.37jmrl325mefilm.tabl.

37,sme /325mefilm.tabl.

80,4 UNIPHARMA

Berlin-Chemie AG

600

600

600

600

600

30

I0,134

.2383

TORASEMIDE


TORASEMIDE

TRAMADOL

1 CoOapMa TpeiAxHr AA

2 OboHrkc

TRAM AD O LHY D RO C H LO RI D E/P

ARACETAMOL

7 MedeKcOOA

2 OboHh(c OapMa EOOA

5000

5000

s000

a

0,78

98 Men

3900 CooapMa AA

4356 STADA

KRKA, d,d,,

204]0 Slovenio

3158 POLPHARMA

Pharmaceutical

32,76 AKTABHC AALaboratorios

157,98 Belmac,

BernpoM AL11,94 Elrrapxf,

BERLIN CHEMIE

MENARI lOO

12000 I

720(n 0,17

12000 0,2u

100

54,39

TRIMETAZIOINE

DIHYDROCHLORIDE

I OboHxxc OapMa EOOA BAC|{OTA31.iH TAE t. 35Mr X 60

35ma tobl.

35m8 tabl.

tabl.

2% 40o qel.

2% 40g, Eel,2%

a0,0546

0,2633

a

2,388

600

600

5

5

5

TESATPtIM 35Mr x

Troxerutln VP, Gel, 2 %40 g, -,Packl1

2

TROXERUTIN INDOMETHACIN 45a, oel.

5

6arxaHOapMa

100

TUBERCULIN

1 Obo8rxc OapMa EOOA

TySEPKyIhH nnA On, 5TU/o,!MIlMI X 10

IYEEPKYnhH nnA 0r. 5TU/0.1M,

1M, x 10

5 TU/o.1ml 1ml omp.

5 TU/o.lm| lml amp.

250mo cops,

250m9 caps.

lq fl.

lc fl.lc fl.

20

20

200 a

200 0,078

200 a

200 0,288

59s 6,96

5 I,Z

10000 a

10000 0,6

2000 I

2000 0,6

159

15 L,28

15 7,32

50

50 47

a

8,046

VALPROIC ACID


2

2

2

2

2

URSODEOXYCHOLIC ACID

,. OboHxxc OapMa EOOA yP3olDA,H XAnC, 250Mr X 100

YPCOOMK xanc. 250Mrx 100

KOHEy,|EKC XAnC. 500Mr X 100

ROHBYTIEKC (anc. 500Mr x 100

l{Cl,lrloMETA3O,l,lH Kanxx 3a Hoc

0.05% 10M,Kch.fl OMETA30/[4H CO/t.

5o0ma tobl.

500m9 tabl,

tabl.

t{oHBvIEKC XAnC. 300Mr X 100

3O0mq tdbl.

300m9 tabl.

Kanc 300Mr x 100 tabl.

AEnAXXH OI.400MI 4MI X 4 400m8/4ml amp.

aMn. 400Mr/4Mr x 4

300 ma tobl,prolono

KOHBYTIEI{C XPOHO 16. 300Mrx 100 300

500 ma tobl.prolono

l(OHBY,lEl{C XPOHO 6. 500Mr x 30

15Omo film.tobl.

16. 160Mr film.tabl.

50

50

50

4

I6,774

100

100 0,4487

100

200

200 0,1297

200 0.1316

160,92 6vI 511O-Hq3n5

Ev/l 51,,!o-Hu3n5

44,87 EWOPHARMA

Klocke Pharma

9 Servic

1200 CoOapMa A.q

GEDEON RICHTER

Pharmaceutical

19,2 Works

Pharmac€utical

37,5 Works

38,88 POLPHARMA

G.L.Pharma GmbH

G.t.PHARMA

15,5 GMBH

17.4 G.L.Pharma GmbH

338,7 SANOFI AVENTIS

Sanofi

G.L,Pharma GmbH

57,6 G.L.Pharma GmbH

19,017 Medoch€mie

"YdilKo$op$o49SO Bucoxoxo 100

5064 FRESENIUSXABI 97,75

chephasaar Chem.-

34,8 XIiMAKC 100

Tarchomin

G.t.PHARMA

25,94 GMBH

An00 Gedeon Richter Plc.

6048 GEDEON RICHTER

VALPROIC ACID


VALPROIC ACID

1 OboHxxc rDapMa EOOA

VALPROIC ACID

VALPROIC ACID

VALSARTAN

VALSARTAN /

VANCOMYCINE

7 fwz$cxo ,uzo2 OboHuxcOopMoEOOA

VA'ELINUM ALEUM

1 OboHrRc OapMa EOOA

voncocin CP powdet fil solution fotlnfusion 7g x 70

BAHKOMU4UH KA6t4 On. ffPBAHKOMhqIH Or. Xrp 15Mr x 5-

Mt,ln

BA3E'HH 9OOT X

BA3E,OhH 6f,/I 900rp - XxMaxc

l,l3oNOP aMn.

I(ABUHTOH aMn. 10Mr/2Mr x 10

l{ABl4HTOH AMn. 5Ml lMt 2Mn X

BhqEThH aMtr. sMr/Mr 2Mr x l0KABI4HTOH AMN. 5MIIMN 2MNX

300

300

90490 0,2113

100

r00

1000

ilxn7000

1000

a

4,95

5,064

ft. 7

VERAPAMIL

VINPOCE|INE


2 OboHxxc OapMa

VINPOCETINE

1 CooapMa TpeiAf,Hr Alq

XYLOMETHMOLINE

1 CooapMaTp€iA{xrAA

2 OboHxxc OapMa

XYLOMETHMOLINE


2 OboHtrKc OapMa EOOA

ZOFENOPRIL CALCIUM

ZOFENOPRIL CALCIUM

1 (DhoHrKc

AMINO ACID +GLUCOSE

19%+PURIFIED SOYBEAN OIL

20%.1540M1

I OboHx(c

AMINO ACID 11%+GLUCOSE

11%+PURIFIEO SOYBEAN OIL

20%.1440M1

AAANTUPAHO MllNRO 3A

AEUA OT O I],O 6 MECEUA

KcllrlOMETA3OrlllH xanxf, 3a hoc

O,t%I.OM[xch/loMETffi o.rt hH con. 0,L%

10M,n

900a uno,

9O0t ung.

70ma 2ml omp,

10mg 2ml amp.

2ml

5 mo/ml - 2 ml omp.

5 m&/ml - 2 ml amp.

-2ml

0.05% -10m1 sol.

0,05% -10m1 sol.

0,7% -7oml sol.

0,1% .10m1 sol,

0,1% -10m1 sol.

7,5ma film.tobl.

1s9

15 2,5

7

56

56

140

140

BERLIN CHEMIE

MENARI

30ma film.tobl.

1540ml 1410kcol

emuls. for inf.

1540 ml l400kcalKA6l,IBTH co,l.1540MI for lnf.

7440m1 T1OOkcol

emuls, for inf.

1440m1 1000kcall{A6l,lBEH nEP}IOEPM COrl,1440Mrl emuls, for lnf.

4O0a onax,

AAAnT. MIf,KO OPh3OnAK 1 40OrP

+ rbx],lqNA

EERLIN CHEMIE

71,12 MENARI

2376 FRESENIUS KABI

2221,8 FRESENIUS NABI

AMINO ACID HEPA 8% 500m1 sol.inf.1152 FRIESLAND

AMINOACIDS

I OhoHrxc Oa

AMINOACIOS

I OboHxxc

10% 500!11 sol.lnf.

AMI{HOBEH COrl.lO% 500M, 1Ot6 sooint sol.lnf.100100

200

200

132 FRESENIUS XABI

FRESENIUS XAEI

B,8RAUN

1944 MEtsUNGEN

Documents

H:#ffiHffi*? · Morr.rsu: flpeAnoxeHuflTa Ha BoI,I.IKTI KnacupaHr.I yqacrHr,rur4 orroBap{T Ha Mr.rrrrlMaJrHI,ITe aAMI{HucrparuIBHv\ Srznanconra u rexHl,Iqecr[ Lr3r,rcKBaHr.I.fl 3a